Impact of the vitamin D deficiency on COVID-19 infection and morality in Asian countries

Jayawardena R, Jeyakumar DT, Francis TV, Misra A.

Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic

Shimels T, Asrat Kassu R, Bogale G, Bekele M, Getnet M, Getachew A, Shewamene Z, Abraha M.

Pre-infection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study

Hayek S, Ben-Shlomo Y, Balicer R, Byrne K, Katz M, Kepten E, Raz I, Roitman E, Zychma M, Barda N.

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, Thurow J, Wagner D, Waller C, Niesen WD, Frings L, Urbach H, Prinz M, Weiller C, Schroeter N, Meyer PT.

Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta-analysis, and meta-regression

Saha S, Al-Rifai RH, Saha S.

Evaluation of simple and cost-effective immuno- haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India

Ramesh J, Reddy SLS, Rajesh M, Varghese J.

Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection

Ünsal YA, Gül ÖÖ, Cander S, Ersoy C, Aydemir E, Ateş C, Uzun Z, Armağan E, Ünsal O, Ertürk E.

Covid-19 and diabetes in primary care - How do hematological parameters present in this cohort?

Varma A, Dergaa I, Mohammed AR, Abubaker M, Al Naama A, Mohammed S, Rafique MA, Manu L, Vedasalam S, Parveze P, Hammouda O, Ammar A.

Diabetes and COVID-19

Gazzaz ZJ.

Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression

Hariyanto TI, Kurniawan A.

Letter to the Editor in response to article: Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis (Martha et al.)

Siniorakis EE, Arvanitakis SG, Elkouris MJ.

Letter to the editor in response to: Effect of COVID-19 lockdown on patients with chronic diseases

Pathak SK, Salunke AA, Pandey A, Singh M, Chawla J, Sharma A.

Psychometric Analysis for fear of COVID-19 Scale (FCV-19S) and its association with depression in patients with diabetes: A cross sectional study from a Tertiary Care Centre in Karachi, Pakistan

Basit KA, Zafar AB, Fawwad A, Waris N, Shaheen F, Basit A.

Antithyroid arthritis syndrome in a case of post-COVID-19 subacute thyroiditis

Ghosh R, Dubey S, Sarkar A, Biswas D, Ray A, Roy D, Chatterjee S, Benito-León J.

What Indians Think of the COVID-19 vaccine: A qualitative study comprising focus group discussions and thematic analysis

Kumari A, Ranjan P, Chopra S, Kaur D, Kaur T, Kalanidhi KB, Goel A, Singh A, Baitha U, Prakash B, Vikram NK.

Analyzing Indian general public's perspective on anxiety, stress and trauma during Covid-19 - A machine learning study of 840,000 tweets

Praveen SV, Ittamalla R, Deepak G.

Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes

Rodriguez Escobedo R, Alonso Felgueroso C, Martinez Tames G, Sanchez Ragnarsson C, Menendez Torre EL.

THE PROGNOSTIC ROLE OF HYPERGLYCEMIA AND GLUCOSE VARIABILITY IN COVID-RELATED ACUTE RESPIRATORY DISTRESS SYNDROME

Lazzeri C, Bonizzoli M, Batacchi S, Di Valvasone S, Chiostri M, Peris A.

EFFECT OF RAMIPRIL ON KIDNEY, LUNG AND HEART ACE2 IN A DIABETIC MICE MODEL

Vergara A, Jacobs-Cachá C, Molina-Van den Bosch M, Domínguez-Báez P, Benito B, García-Carro C, Serón D, Soler MJ.

Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, Kar P, Meace C, Sattar N, Sharp S, Wareham NJ, Weaver A, Woch E, Young B, Valabhji J.

Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?

Schernthaner G.

No Negative Impact of a National State of Emergency by COVID-19 Outbreak on Hemoglobin A1c Levels in Patients with Type 2 Diabetes Living in Semi-Rural Japan

Aso Y, Iijima T, Tomaru T, Jojima T, Usui I.

Impact of the COVID-19 Epidemic on hospitalization for diabetic foot ulcers during lockdown: A French nationwide population-based study

Mariet AS, Benzenine E, Bouillet B, Vergès B, Quantin C, Petit JM.

Diabetes and susceptibility to COVID-19: may miR-146a make the difference between life and death?

Mormile R.

Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus

Li W, Li J, Wei Q, McCowen K, Xiong W, Liu J, Jiang W, Thomas R, Hepokoski M, He M, Shyy J, Malhotra A, Xiong N.

Continuous Glucose Monitoring in the Hospital

Perez-Guzman MC, Shang T, Zhang JY, Jornsay D, Klonoff DC.

Evaluation for the Feasibility and Accuracy of Freestyle Libre Flash Glucose Monitoring System Used By COVID-19 Patients in Intensive Care Unit

Zhang Y, Liu X, Zhang J, Fu J, Li S, Chen S, Chen Y, Lu B.

A potential impact of SARS-CoV-2 on pituitary glands and pituitary neuroendocrine tumors

Gu WT, Zhou F, Xie WQ, Wang S, Yao H, Liu YT, Gao L, Wu ZB.

ASSOCIATION OF HYPERGLYCAEMIA WITH HOSPITAL MORTALITY IN NONDIABETIC COVID-19 PATIENTS: A COHORT STUDY

Mamtani M, Athavale AM, Abraham M, Vernik J, Amarah AR, Ruiz JP, Joshi AJ, Itteera M, Zhukovski SD, Madaiah RP, White BC, Hart P, Kulkarni H.

Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice

Novoselova EG, Glushkova OV, Lunin SM, Khrenov MO, Parfenyuk SB, Novoselova TV, Sharapov MG, Gordeeva AE, Novoselov VI, Fesenko EE.

Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis

Kaminska H, Szarpak L, Kosior D, Wieczorek W, Szarpak A, Al-Jeabory M, Gawel W, Gasecka A, Jaguszewski MJ, Jarosz-Chobot P.

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients

Han M, Ma K, Wang X, Yan W, Wang H, You J, Wang Q, Chen H, Guo W, Chen T, Ning Q, Luo X.

Thyroiditis and SARS-CoV-2 pandemic: a review

Caron P.

TELEASSISTANCE IN PATIENTS WITH TYPE 1 DIABETES DURING COVID-19 PANDEMIC: RESULTS FROM A PILOT STUDY

Parise M, Tartaglione L, Cutruzzolà A, Maiorino MI, Esposito K, Pitocco D, Gnasso A, Irace C.

Severe SARS-CoV-2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53-year man with hypertension

Ali E, Badawi M, Ahmed A, Abdelmahmuod E, Ibrahim W.

Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the pandemic of coronavirus disease 2019 in Japan

Takahara M, Watanabe H, Shiraiwa T, Maeno Y, Yamamoto K, Shiraiwa Y, Yoshida Y, Nishioka N, Katakami N, Shimomura I.

Antioxidants other than vitamin C may be detected by glucose meters: immediate relevance for patients with disorders targeted by antioxidant therapies

Grzych G, Pekar JD, Chevalier-Curt MJ, Decoin R, Vergriete P, Henry H, Odou P, Maboudou P, Brousseau T, Vamecq J.

Association of the host genetic factors, hypercholesterolemia and diabetes with mild influenza in an Iranian population

Mehrbod P, Eybpoosh S, Farahmand B, Fotouhi F, Khanzadeh Alishahi M.

Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects

Lisco G, De Tullio A, Jirillo E, Giagulli VA, De Pergola G, Guastamacchia E, Triggiani V.

Effect of COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study

D'Onofrio L, Pieralice S, Maddaloni E, Mignogna C, Sterpetti S, Coraggio L, Luordi C, Guarisco G, Leto G, Leonetti F, Manfrini S, Buzzetti R.

Criticism of best practice statement related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels

Van Dril L, Schumacher C.

Updated best practice statements regarding sodium-glucose cotransporter-2 inhibitors and serum potassium levels

Pamulapati LG, Rochester-Eyeguokan CD, Pincus KJ.

Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study

Dyusupova A, Faizova R, Yurkovskaya O, Belyaeva T, Terekhova T, Khismetova A, Sarria-Santamera A, Bokov D, Ivankov A, Glushkova N.

Caring for caregivers: the impact of the COVID-19 pandemic on those responsible for children and adolescents with type 1 diabetes

Alessi J, de Oliveira GB, Feiden G, Schaan BD, Telo GH.

Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19)

Okauchi Y, Matsuno K, Nishida T, Sawada K, Kawasaki A, Ito N, Morimura O, Otani Y, Yokoe M, Abe K, Iwahashi H.

Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose

Wang Z, Du Z, Zhao X, Guo F, Wang T, Zhu F.

Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review

Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS.

Diabetes and COVID-19: Diseases of racial, social and glucose intolerance

Chowdhury TA.

Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

Moreno R, Díez JL, Diarte JA, Salinas P, de la Torre Hernández JM, Andres-Cordón JF, Trillo R, Briales JA, Amat-Santos I, Romaguera R, Díaz JF, Vaquerizo B, Ojeda S, Cruz-González I, Morena-Salas D, Pérez de Prado A, Sarnago F, Portero P, Gutierrez-Barrios A, Alfonso F, Bosch E, Pinar E, Ruiz-Arroyo JR, Ruiz-Quevedo V, Jiménez-Mazuecos J, Lozano F, Rumoroso JR, Novo E, Irazusta FJ, García Del Blanco B, Moreu J, Ballesteros-Pradas SM, Frutos A, Villa M, Alegría-Barrero E, Lázaro R, Pare

Pathophysiological Implication of Vitamin D in Diabetic Kidney Disease

Galuška D, Pácal L, Kaňková K.

Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management

Holland D, Heald AH, Stedman M, Green L, Scargill J, Duff CJ, Hanna FWF, Wu P, Halsall I, Gaskell N, Fryer AA.

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19

Rhee SY, Lee J, Nam H, Kyoung DS, Shin DW, Kim DJ.

Islet organoid as a promising model for diabetes

Zhang X, Ma Z, Song E, Xu T.

Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases

Koufakis T, Pavlidis AN, Metallidis S, Kotsa K.

COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity

Kim ES, Kwon Y, Choe YH, Kim MJ.

Rhabdomyolysis plus Hypocalcemia and Diabetic Ketoacidosis as Concurrent Rare COVID-19 Manifestations

Heidarpour M, Vakhshoori M, Haghighatpanah MA, Ashrafi L, Khorvash F, Iraj B.

Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes

Rahmani-Kukia N, Abbasi A.

Diabetes is associated with higher mortality and severity in hospitalized patients with COVID-19

Moghaddam Tabrizi F, Rasmi Y, Hosseinzadeh E, Rezaei S, Balvardi M, Kouchari MR, Ebrahimi G.

Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study

Cheng X, Xin S, Chen Y, Li L, Chen W, Li W, Zhou B, Li C, Gong Y, Li F, Duan P, Zhou X.

Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children during the COVID-19 Pandemic

Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay JA, Brockman N, Rath M, Doulla M.

[Checklist for patients with type 2 diabetes mellitus for remote consultation]

Angullo-Martínez E, Carretero-Anibarro E, Sánchez Barrancos IM, Cos Claramunt X, Orozco Beltrán D, Torres Baile JL, Ezkurra Loiola P; en representación del Grupo de Trabajo de Diabetes de la SemFyC; en representación del Grupo de Trabajo de Diabetes de la SemFyC.

Effectiveness of remote continuous glucose monitoring on adverse outcomes among patients with diabetes complicated with COVID-19

Shen Y, Zhang L, Fan X, Zhou J.

Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19

Moin ASM, Sathyapalan T, Diboun I, Atkin SL, Butler AE.

Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul

Satman I, Demirci I, Haymana C, Tasci I, Salman S, Ata N, Dagdelen S, Sahin I, Emral R, Cakal E, Atmaca A, Sahin M, Celik O, Demir T, Ertugrul D, Unluturk U, Yalcin Arga K, Caglayan M, Sonmez A.

Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply

Colhoun HM, McGurnaghan SJ, McKeigue PM.

Microvascular disease in diabetes and severe COVID-19 outcomes

Corcillo A, Whyte MB, Vas P, Karalliedde J.

Telemedicine and urban diabetes during COVID-19 pandemic in Milano, Italy during lock-down: epidemiological and sociodemographic picture

Luzi L, Carruba M, Crialesi R, Da Empoli S, Dagani R, Lovati E, Nicolucci A, Berra CC, Cipponeri E, Vaccaro K, Lenzi A.

Hypovitaminosis D and the endocrine phenotype of COVID-19

Giustina A.

SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice

Ma Y, Lu D, Bao L, Qu Y, Liu J, Qi X, Yu L, Zhang X, Qi F, Lv Q, Liu Y, Shi X, Sun C, Li J, Wang J, Han Y, Gao K, Dong W, Liu N, Gao S, Xue J, Wei Q, Pan S, Gao H, Zhang L, Qin C.

Editor's Comment. Caution: The Intersection of Diabetes and COVID-19

Chernoff A.

Diabetic Ketoacidosis at Emergency Department Presentation During the First Months of the SARS-CoV-2 Pandemic in Israel: A Multicenter Cross-Sectional Study

Jacob R, Weiser G, Krupik D, Takagi D, Peled S, Pines N, Hashavya S, Gur-Soferman H, Gamsu S, Kaplan O, Maimon M, Oren S, Padeh G, Shavit I.

An electrochemical SARS-CoV-2 biosensor inspired by glucose test strip manufacturing processes

Vezza VJ, Butterworth A, Lasserre P, Blair EO, MacDonald A, Hannah S, Rinaldi C, Hoskisson PA, Ward AC, Longmuir A, Setford S, Farmer ECW, Murphy ME, Corrigan DK.

Diabetes management by either telemedicine or clinic visit improved glycemic control during COVID-19 pandemic state of emergency in Japan

Onishi Y, Yoshida Y, Takao T, Tahara T, Kikuchi T, Kobori T, Kubota T, Shimmei A, Iwamoto M, Kasuga M.

Telehealth strategy to mitigate the negative psychological impact of the COVID-19 pandemic on type 2 diabetes: A randomized controlled trial

Alessi J, de Oliveira GB, Franco DW, Becker AS, Knijnik CP, Kobe GL, Amaral BB, de Brito A, Schaan BD, Telo GH.

Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic

Hasan S, Cecilia Lansang M, Salman Khan M, Dasenbrook E.

Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy

Falcetta P, Aragona M, Ciccarone A, Bertolotto A, Campi F, Coppelli A, Dardano A, Giannarelli R, Bianchi C, Del Prato S.

Letter to the editor in response to the article: "Vitamin D concentrations and COVID-19 infection in UK biobank" (Hastie et al.)

Davies G, Mazess RB, Benskin LL.

Following SARS-CoV-2 in the first trimester of pregnancy, what should we do in the 2nd, 3rd trimesters, and postpartum in terms of thyroid assessment?

Sarahian N, Saei Ghare Naz M, Ramezani Tehrani F.

Impact of lockdown during COVID-19 emergency on glucose metrics of children and adolescents with type 1 diabetes in Piedmont, Italy

Tinti D, Savastio S, Grosso C, De Donno V, Trada M, Nugnes M, Bertelli E, Franceschi L, Marchisio M, Pozzi E, Tappi E, Felici E, De Sanctis L, Rabbone I.

Disparities in Telemedicine Use for Subspecialty Diabetes Care During COVID-19 Shelter-In-Place Orders

Haynes SC, Kompala T, Neinstein A, Rosenthal J, Crossen S.

Follow-Up of a Massive Open Online Course in Type 2 Diabetes Self-Management Education

Mackenzie SC, Cumming KM, Garrell D, Brodie D, Wilson L, Mehar S, Cunningham SG, Bickerton A, Wake DJ.

Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irrespective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India

Gupta A, Nayan N, Nair R, Kumar K, Joshi A, Sharma S, Singh J, Kapoor R.

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin

Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE.

SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis

Moorthy A, Gaikwad R, Krishna S, Hegde R, Tripathi KK, Kale PG, Rao PS, Haldipur D, Bonanthaya K.

Development and validation of a questionnaire to assess socio-behavioural impact of COVID-19 on the general population

Bandhu Kalanidhi K, Ranjan P, Sarkar S, Kaur T, Dutt Upadhyay A, Singh A, Sahu A, Khan M, Vijay Prasad B, Baitha U, Kumar A.

Analyzing the attitude of Indian citizens towards COVID-19 vaccine - A text analytics study

Praveen SV, Ittamalla R, Deepak G.

The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19

Grondman I, de Nooijer AH, Antonakos N, Janssen NAF, Mouktaroudi M, Leventogiannis K, Medici M, Smit JWA, van Herwaarden AE, Joosten LAB, van der Veerdonk FL, Pickkers P, Kox M, Jaeger M, Netea MG, Giamarellos-Bourboulis EJ, Netea-Maier RT.

Clinical course and outcome of patients with ACTH-dependent Cushing's syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations

Belaya Z, Golounina O, Melnichenko G, Tarbaeva N, Pashkova E, Gorokhov M, Kalashnikov V, Dzeranova L, Fadeev V, Volchkov P, Dedov I.

A systematic review of clinical and laboratory parameters associated with increased severity among COVID-19 patients

Mehta AA, Haridas N, Belgundi P, Jose WM.

HbA1c and BMI after lockdown for COVID-19 in children and adolescents with type 1 diabetes mellitus

Cognigni M, D'Agostin M, Schiulaz I, Giangreco M, Carletti C, Faleschini E, Barbi E, Tornese G.

Newly diagnosed diabetes in patients with mild to moderate COVID-19

Sathish T, Chandrika Anton M.

(18)F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine

Steinberg J, Thomas A, Iravani A.

The independent risk of obesity and diabetes and their interaction in COVID-19: A retrospective cohort study

Tchang BG, Askin G, Sahagun A, Hwang J, Huang H, Mendelsohn Curanaj FA, Seley JJ, Safford MM, Alonso LC, Aronne LJ, Shukla AP.

The influence of vitamin-C intake on blood glucose measurements in COVID-19 pandemic

Al-Obaidi ZMJ, Hussain YA, Ali AA, Al-Rekabi MD.

Characteristics of and Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With or Without COVID-19

Pasquel FJ, Messler J, Booth R, Kubacka B, Mumpower A, Umpierrez G, Aloi J.

Determinants of Dietary Adherence Among Type 2 Diabetes Patients Aimed COVID-19 at the University of Gondar Comprehensive Specialized Hospital

Mekonnen CK, Ferede YM, Abate HK.

Impact of COVID-19 Pandemic on the outcomes in patients with Critical Limb Threatening Ischaemia and Diabetic Foot Infection

Musajee M, Zayed H, Thulasidasan N, Sayed M, Francia F, Green M, Arissol M, Lakhani A, Biasi L, Patel S.

Diabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomes

Abdelhafiz AH, Emmerton D, Sinclair AJ.

More Specialties, Less Problems: Using collaborative competency between Infectious Disease, Podiatry, and Pathology to improve the care of patients with diabetic foot osteomyelitis

Jhaveri VV, Sullivan C, Ward A, Giurini J, Karchmer AW, Stillman IE, Davis RB, Freed JA, LaSalvia MT, Stead W.

New-Onset Diabetes in Children during COVID-19: Clinical Case Report

Aabdi M, Aarab A, Es-Saad O, Malki K, Bkiyar H, Housni B.

Elevated glucose level leads to rapid COVID-19 progression and high fatality

Wang W, Shen M, Tao Y, Fairley CK, Zhong Q, Li Z, Chen H, Ong JJ, Zhang D, Zhang K, Xing N, Guo H, Qin E, Guan X, Yang F, Zhang S, Zhang L, He K.

Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19

Tzoulis P, Waung JA, Bagkeris E, Hussein Z, Biddanda A, Cousins J, Dewsnip A, Falayi K, McCaughran W, Mullins C, Naeem A, Nwokolo M, Quah H, Bitat S, Deyab E, Ponnampalam S, Bouloux PM, Montgomery H, Baldeweg SE.

Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis

Corona G, Pizzocaro A, Vena W, Rastrelli G, Semeraro F, Isidori AM, Pivonello R, Salonia A, Sforza A, Maggi M.

Impact of diabetes on COVID-19 and other infection: report from the 22(nd) Hong Kong Diabetes and Cardiovascular Risk Factors - East Meets West Symposium

Luk AOY, Ng SSS, Holt RI.

Glycemic fluctuations caused by COVID-19: results from continuous glucose monitoring

Shen Y, Zhang L, Fan X, Zhou J.

Cardiovascular complications in COVID-19 patients with or without diabetes mellitus

Abe T, Egbuche O, Igwe J, Jegede O, Wagle B, Olanipekun T, Onwuanyi A.

Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System

Roberts J, Pritchard AL, Treweeke AT, Rossi AG, Brace N, Cahill P, MacRury SM, Wei J, Megson IL.

The gender differences as a risk factor in diabetic patients with COVID-19

Belice T, Demir I.

COVID-19-Induced Diabetic Ketoacidosis in an Adult with Latent Autoimmune Diabetes

Omotosho YB, Ying GW, Stolar M, Mallari AJP.

SARS-CoV-2 infection and diabetes mellitus: A North Eastern Romanian experience

Manciuc C, Nemescu D, Vata A, Lacatusu GA.

Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients

Zhao Y, Liu Y, Yi F, Zhang J, Xu Z, Liu Y, Tao Y.

Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study

Wargny M, Potier L, Gourdy P, Pichelin M, Amadou C, Benhamou PY, Bonnet JB, Bordier L, Bourron O, Chaumeil C, Chevalier N, Darmon P, Delenne B, Demarsy D, Dumas M, Dupuy O, Flaus-Furmaniuk A, Gautier JF, Guedj AM, Jeandidier N, Larger E, Le Berre JP, Lungo M, Montanier N, Moulin P, Plat F, Rigalleau V, Robert R, Seret-Bégué D, Sérusclat P, Smati S, Thébaut JF, Tramunt B, Vatier C, Velayoudom FL, Vergès B, Winiszewski P, Zabulon A, Gourraud PA, Roussel R, Cariou B, Hadjadj S; CORONADO invest

Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients?

Zubkiewicz-Kucharska A, Seifert M, Stępkowski M, Noczyńska A.

Lifestyle changes by COVID-19 containment measure: body weight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency

Tanaka N, Hamamoto Y, Kurotobi Y, Yamasaki Y, Nakatani S, Matsubara M, Haraguchi T, Yamaguchi Y, Izumi K, Fujita Y, Kuwata H, Hyo T, Yamada Y, Kurose T, Seino Y.

Obesity and COVID-19 in Adult Patients With Diabetes

Cao P, Song Y, Zhuang Z, Ran J, Xu L, Geng Y, Han L, Zhao S, Qin J, He D, Wu F, Yang L.

l-Cysteine Stimulates the Effect of Vitamin D on Inhibition of Oxidative Stress, IL-8, and MCP-1 Secretion in High Glucose Treated Monocytes

Jain SK, Micinski D, Parsanathan R.

Vitamin D supplementation in diabetic retinopathy in the era of COVID-19

Saxena S.

The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation

McGovern AP, Thomas NJ, Vollmer SJ, Hattersley AT, Mateen BA, Dennis JM.

Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection

Vargas-Vázquez A, Bello-Chavolla OY, Ortiz-Brizuela E, Campos-Muñoz A, Mehta R, Villanueva-Reza M, Bahena-López JP, Antonio-Villa NE, González-Lara MF, Ponce de León A, Sifuentes-Osornio J, Aguilar-Salinas CA.

Letter to the Editor Regarding: Experience from Implementing Telemetric In-Hospital Continuous Glucose Monitoring During the COVID-19 Pandemic

Klarskov CK, Kristensen PL.

When Scarcity Meets Disparity: "Resources Allocation and COVID-19 Patients with Diabetes"

Appel JM.

The association between COVID-19 and type 1 diabetes mellitus: A systematic review

Nassar M, Nso N, Baraka B, Alfishawy M, Mohamed M, Nyabera A, Sachmechi I.

Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c

Roberts AJ, Malik F, Pihoker C, Dickerson JA.

Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification

Misra A, Ghosh A, Gupta R.

The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19

Shah H, Khan MSH, Dhurandhar NV, Hegde V.

ICAM-1 levels in patients with covid-19 with diabetic foot ulcers: A case-controlled, prospective, cohort study in southeast asia

Oley MH, Oley MC, Kepel BJ, Tjandra DE, Fredrik G Langi FL, Herwen, Aling DMR, Joicetine Wagiu AM, Faruk M.

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections

Sun B, Huang S, Zhou J.

Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients

Moftakhar L, Moftakhar P, Piraee E, Ghaem H, Valipour A, Azarbakhsh H.

Hydroxychloroquine sulfate related hypoglycemia in a non-diabetic COVID-19 patient: a case report and literature review

Imanova Yaghji N, Kan EK, Akcan S, Colak R, Atmaca A.

Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic-A comprehensive review

Piticchio T, Le Moli R, Tumino D, Frasca F.

Grocery food taxes and U.S. county obesity and diabetes rates

Wang L, Zheng Y, Buck S, Dong D, Kaiser HM.

Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study

Oh TK, Song IA.

A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India

Gupta Y, Goyal A, Kubihal S, Golla KK, Tandon N.

Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: results from the CORONADO study

Cariou B, Pichelin M, Goronflot T, Gonfroy C, Marre M, Raffaitin-Cardin C, Thivolet C, Wargny M, Hadjadj S, Gourdy P; CORONADO investigators.

DIABETES MELLITUS IN COVID-19 PATIENTS: VERDICT OR NOT?

Halushko OA, Trishchynska MA, Povietkina TM, Boliuk MV.

Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients

Singh Y, Gupta G, Anand K, Kumar Jha N, Thangavelu L, Kumar Chellappan D, Dua K.

A Case of Fatal Rhino-Orbital Mucormycosis Associated With New Onset Diabetic Ketoacidosis and COVID-19

Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon S, Romero-Gutierrez L.

Thresholds of Glycemia and the Outcomes of COVID-19 Complicated With Diabetes: A Retrospective Exploratory Study Using Continuous Glucose Monitoring

Shen Y, Fan X, Zhang L, Wang Y, Li C, Lu J, Zha B, Wu Y, Chen X, Zhou J, Jia W.

Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark

Madsen KP, Willaing I, Rod NH, Varga TV, Joensen LE.

A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes

Riddle MC, Bakris G, Blonde L, Boulton AJM, D'Alessio D, DiMeglio LA, Gonder-Frederick L, Hood KK, Hu FB, Kahn SE, Kaul S, Leiter LA, Moses RG, Rich SS, Rosenstock J, Wylie-Rosett J.

COVID-19 pandemic gestational diabetes screening guidelines: A retrospective study in Australian women

Zhu S, Meehan T, Veerasingham M, Sivanesan K.

First televisits provided by the Public Health System for patients affected by diabetes mellitus in COVID-19 pandemic

Pintaudi B, Garavaglia G, Disoteo O, Meneghini E, Massimiliano Epis O, Colombo F, Bertuzzi F.

Shaping Workflows in Digital and Remote Diabetes Care During the COVID-19 Pandemic: A Service Design Approach

Braune K, Boss K, Schmidt-Herzel J, Gajewska KA, Thieffry A, Schulze L, Posern B, Raile K.

Craniofacial pain in COVID-19 patients with diabetes mellitus: Clinical and laboratory description of 21 cases

Badrah M, Riad A, Kassem I, Boccuzzi M, Klugar M.

Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates

Elemam NM, Hannawi H, Salmi IA, Naeem KB, Alokaily F, Hannawi S.

Challenges in diabetic foot treatment during pandemic of COVID-19

Vukas H, Piljic D, Kadić-Vukas S, Piljic D.

Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept

Davis GM, Faulds E, Walker T, Vigliotti D, Rabinovich M, Hester J, Peng L, McLean B, Hannon P, Poindexter N, Saunders P, Perez-Guzman C, Tekwani SS, Martin GS, Umpierrez G, Agarwal S, Dungan K, Pasquel FJ.

Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes

Wang J, Cooper JM, Gokhale K, Acosta-Mena D, Dhalla S, Byne N, Chandan JS, Anand A, Okoth K, Subramanian A, Bangash MN, Jackson T, Zemedikun D, Taverner T, Hanif W, Ghosh S, Narendran P, Toulis K, Tahrani A, Surenthirakumaran R, Adderley NJ, Haroon S, Khunti K, Sainsbury C, Thomas GN, Nirantharakumar K.

The cytokine storm and thyroid hormone changes in COVID-19

Croce L, Gangemi D, Ancona G, Liboà F, Bendotti G, Minelli L, Chiovato L.

Is prediabetes a risk factor for severe COVID-19?

Sathish T, Devi N.

Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study

Dżygało K, Nowaczyk J, Szwilling A, Kowalska A.

Risk Factors in Patients with Diabetes Hospitalized for COVID-19: Findings from a Multicenter Retrospective Study

Zhang Y, Wang J, Tan N, Du K, Gao K, Zuo J, Lu X, Ma Y, Hou Y, Li Q, Xu H, Huang J, Huang Q, Na H, Wang J, Wang X, Xiao Y, Zhu J, Chen H, Liu Z, Wang M, Zhang L, Guo S, Wang W.

Isolation and Education During a Pandemic: Novel Telehealth Approach to Family Education for a Child With New-Onset Type 1 Diabetes and Concomitant COVID-19

Shawar RS, Cymbaluk AL, Bell JJ, Patel T, Treybig CW, Poland TR, DeSalvo DJ, Sonabend RY, Lyons SK, Lin Y.

[Vulnerability and health risks of people with diabetes to COVID-19]

Santillán-García A.

Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients With Type 2 Diabetes

Noh Y, Oh IS, Jeong HE, Filion KB, Yu OHY, Shin JY.

Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes

Jia X, Gesualdo P, Geno Rasmussen C, Alkanani AA, He L, Dong F, Rewers MJ, Michels AW, Yu L.

COVID-19 and Diabetic Ketoacidosis: A Single Center Experience

Singh B, Kaur P, Patel P, Reid RJ, Kumar A, Kaur S, Guragai N, Rushdy A, Bikkina M, Shamoon F.

The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia

Alharthi SK, Alyusuf EY, Alguwaihes AM, Alfadda A, Al-Sofiani ME.

Glycemic control in type 1 diabetes children and teenagers around lockdown for COVID-19: a continuous glucose monitoring based observational study

Wu X, Luo S, Zheng X, Ding Y, Wang S, Ling P, Yue T, Xu W, Yan J, Weng J.

Non autoimmune type 1B diabetes after mild COVID-19: Report of three cases

Seow CJ, Wei Choon Koh A, Lian JX, Dalan R, Boehm BO.

Diabetic neuropathy: a risk factor for severe COVID-19?

Pitocco D, Viti L, Santoliquido A, Tartaglione L, Di Leo M, Bianchi A, Caputo S, Pontecorvi A.

Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy

Marigliano M, Maffeis C.

Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global survey

Scott SN, Fontana FY, Züger T, Laimer M, Stettler C.

Role of self-care in COVID-19 pandemic for people living with comorbidities of diabetes and hypertension

Gupta SK, Lakshmi PVM, Kaur M, Rastogi A.

COVID-19 and emergencies in patients with diabetes: two case reports

Dey RK, Hilmy AI, Imad HA, Yoosuf AA, Latheef AA.

Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity

Fedullo AL, Schiattarella A, Morlando M, Raguzzini A, Toti E, De Franciscis P, Peluso I.

Diabetes Care During COVID-19 Pandemic in Singapore Using a Telehealth Strategy

Lian X, Dalan R, Seow CJ, Liew H, Jong M, Chew D, Lim B, Lin A, Goh E, Goh C, Othman NB, Tan L, Boehm BO.

Use of Dipeptidyl Peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: a propensity score analysis from the CORONADO study

Roussel R, Darmon P, Pichelin M, Goronflot T, Abouleka Y, Ait Bachir L, Allix I, Ancelle D, Barraud S, Bordier L, Carlier A, Chevalier N, Coffin-Boutreux C, Cosson E, Dorange A, Dupuy O, Fontaine P, Fremy B, Galtier F, Germain N, Guedj AM, Larger E, Laugier-Robiolle S, Laviolle B, Ludwig L, Monier A, Montanier N, Moulin P, Moura I, Prevost G, Reznik Y, Sabbah N, Saulnier PJ, Serusclat P, Vatier C, Wargny M, Hadjadj S, Gourdy P, Cariou B; CORONADO investigators.

Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein

Koh H, Moh AMC, Yeoh E, Lin Y, Low SKM, Ooi ST, Tan SK, Lin JHX, Hoong CWS.

A novel telemedicine protocol improved outcomes for high-risk patients with type 1 diabetes: A 3-month quality improvement project during the COVID-19 pandemic

Zeller WP Jr, DeGraff R, Zeller W.

A glucose meter interface for point-of-care gene circuit-based diagnostics

Amalfitano E, Karlikow M, Norouzi M, Jaenes K, Cicek S, Masum F, Sadat Mousavi P, Guo Y, Tang L, Sydor A, Ma D, Pearson JD, Trcka D, Pinette M, Ambagala A, Babiuk S, Pickering B, Wrana J, Bremner R, Mazzulli T, Sinton D, Brumell JH, Green AA, Pardee K.

Why access to diabetes care must not be another victim of the COVID-19 pandemic

Boulton A.

The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications

M Tourkmani A, J ALHarbi T, Rsheed AMB, Alrasheedy AA, ALMadani W, ALJuraisi F, AlOtaibi AF, AlHarbi M, AlAbood AF, Alshaikh AA.

Diabetic ketoacidosis at type 1 diabetes onset: indirect impact of COVID-19 pandemic

Lazzeroni P, Bernardi L, Pecora F, Motta M, Bianchi L, Ruozi MB, Giacometti A, Venezia S, Dodi I, Iovane B.

The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: A population-based study

Leon-Abarca JA, Memon RS, Rehan B, Iftikhar M, Chatterjee A.

Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health

Racine-Brzostek SE, Yang HS, Jack GA, Chen Z, Chadburn A, Ketas TJ, Francomano E, Klasse PJ, Moore JP, McDonough KA, Girardin RC, Dupuis Ii AP, Payne AF, Ma L, Sweeney J, Zhong E, Yee J, Cushing MM, Zhao Z.

Metformin: an inexpensive and effective treatment in people with diabetes and COVID-19?

Dardano A, Del Prato S.

EUGLYCEMIC DIABETIC KETOACIDOSIS WITH COVID-19 INFECTION IN PATIENTS WITH TYPE 2 DIABETES TAKING SGLT2 INHIBITORS

Vitale RJ, Valtis YK, McDonnell ME, Palermo NE, Fisher NDL.

COVID-19 PRESENTING WITH DIABETIC KETOACIDOSIS: A CASE SERIES

Gorthi RS, Kamel G, Dhindsa S, Nayak RP.

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes

Crouse AB, Grimes T, Li P, Might M, Ovalle F, Shalev A.

Facilitators and Barriers to Nursing Implementation of Continuous Glucose Monitoring (CGM) in Critically Ill COVID-19 Patients

Faulds ER, Jones L, McNett M, Smetana KS, May CC, Sumner L, Buschur E, Exline M, Ringel MD, Dungan K.

Diabetes is not associated with COVID-19-related mortality in older institutionalized people

Legris P, Vaillard L, Nonciaux C, Hourdain P, Taroux M, Petit JM, Vergès B, Bouillet B.

Management of diabetes and hyperglycaemia in the hospital

Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE.

Robust neutralizing antibodies to SARS-CoV-2 develop and persist in subjects with diabetes and COVID-19 pneumonia

Dispinseri S, Lampasona V, Secchi M, Cara A, Bazzigaluppi E, Negri D, Brigatti C, Pirillo MF, Marzinotto I, Borghi M, Rovere-Querini P, Tresoldi C, Ciceri F, Scavini M, Scarlatti G, Piemonti L.

Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis

Bonora BM, Avogaro A, Fadini GP.

Anosmia and ageusia: a piece of the puzzle in the etiology of COVID-19-related transitory erectile dysfunction

Bertolo R, Cipriani C, Bove P.

Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity

De Groot CJ, Poitou Bernert C, Coupaye M, Clement K, Paschou SA, Charmandari E, Kanaka-Gantenbein C, Wabitsch M, Buddingh EP, Nieuwenhuijsen B, Marina L, Johannsson G, Van Den Akker ELT.

Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?

Rachmiel M, Lebenthal Y, Mazor-Aronovitch K, Brener A, Levek N, Levran N, Chorna E, Dekel M, Barash G, Landau Z, Pinhas-Hamiel O.

Clinical Findings in Diabetes Mellitus Patients with COVID-19

Guo T, Shen Q, Ouyang X, Guo W, Li J, He W, Yu B, Wu C, Zhou Z, Luo H, Peng H.

Prevalence, Risk Factors and Outcomes Associated with Acute Kidney Injury in Patients Hospitalized for COVID-19: A Comparative Study between Diabetic and Nondiabetic Patients

Khalili S, Sabaghian T, Sedaghat M, Soroureddin Z, Askari E, Khalili N.

Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study

Malik SUF, Chowdhury PA, Hakim A, Islam MS, Alam MJ, Azad AK.

Macrolevel association of COVID-19 with non-communicable disease risk factors in India

Gaur K, Khedar RS, Mangal K, Sharma AK, Dhamija RK, Gupta R.

Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2

Bastrup Israelsen S, Pottegård A, Sandholdt H, Madsbad S, Thomsen RW, Benfield T.

Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis

Mrigpuri P, Sonal S, Spalgais S, Goel N, Menon B, Kumar R.

The Usefulness of [(18)F]F-Fluorodeoxyglucose and [(18)F]F-Sodium Fluoride Positron Emission Tomography Imaging in the Assessment of Early-Stage Aortic Valve Degeneration after Transcatheter Aortic Valve Implantation (TAVI)-Protocol Description and Preliminary Results

Sorysz D, Januszek R, Sowa-Staszczak A, Grochowska A, Opalińska M, Bagieński M, Zawiślak B, Dziewierz A, Tokarek T, Krawczyk-Ożóg A, Bartuś S, Dudek D.

Diabetic Foot Disease during the COVID-19 Pandemic

Boulton AJM.

The Dual Burden of Type 1 Diabetes and COVID-19

Gregory JM, Moore DJ.

Limiting the Use of Oral Glucose Tolerance Tests to Screen for Hyperglycemia in Pregnancy during Pandemics

Nachtergaele C, Vicaut E, Tatulashvili S, Pinto S, Bihan H, Sal M, Berkane N, Allard L, Baudry C, Portal JJ, Carbillon L, Cosson E.

Hypocalcemia is associated with severe COVID-19: A systematic review and meta-analysis

Martha JW, Wibowo A, Pranata R.

Impact of COVID-19 outbreak on lifestyle behaviour: A review of studies published in India

Rawat D, Dixit V, Gulati S, Gulati S, Gulati A.

The DAR 2020 Global survey : Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes

Hassanein M, Hussein Z, Shaltout I, Juani Wan Seman W, Chin Voon T, Mohd Noor N, Akif Buyukbese M, El Tony L, Mohamed Shaker G, Alamoudi RM, Hafidh K, Fariduddin M, Batais MA, Shaikh S, Rachid Malek P, Alabbood M, Sahay R, Alshenqete AM, Yakoob Ahmedani M.

Testosterone in COVID-19: Friend or Foe?

Niemann PJ, Goldstein HV.

The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus

Zheng M, Wang X, Guo H, Fan Y, Song Z, Lu Z, Wang J, Zheng C, Dong L, Ma Y, Zhu Y, Fang H, Ye S.

Diabetic Ketoacidosis on Hospitalization with COVID-19 in a Previously Nondiabetic Patient: A Review of Pathophysiology

Eskandarani RM, Sawan S.

Predictors of Mortality in a Multi-Racial Urban Cohort of Persons with Type 2 Diabetes and Novel Coronavirus 19

Myers AK, Kim TS, Zhu X, Liu Y, Qiu M, Pekmezaris R.

Psycho-social and behavioural impact of COVID 19 on young adults: Qualitative research comprising focused group discussion and in-depth interviews

Mazumder A, Bandhu Kalanidhi K, Sarkar S, Ranjan P, Sahu A, Kaur T, Kaur D, Bhattacharya A, Priyadarshini Suna S, Prakash B, Deb KS, Wig N.

Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective

Santacroce L, Inchingolo F, Topi S, Del Prete R, Di Cosola M, Charitos IA, Montagnani M.

Diabetic foot and COVID-19. Medical consultation and severity of lesions compared to 2019

Carro GV, Carlucci EM, Torterola I, Breppe P, Ticona Ortiz MÁ, Palomino Pallarez JE.

COVID-19 vaccine prioritisation for type 1 and type 2 diabetes

Powers AC, Aronoff DM, Eckel RH.

How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit

Zhang JY, Shang T, Ahn D, Chen K, Coté G, Espinoza J, Mendez CE, Spanakis EK, Thompson B, Wallia A, Wisk LE, Kerr D, Klonoff DC.

(Our response to) COVID-19: In science we trust

Filetti S.

Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review

Barengolts E, Smith ED.

Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19

Li J, Wei Q, Li WX, McCowen KC, Xiong W, Liu J, Jiang W, Marin T, Thomas RL, He M, Gongol B, Hepokoski M, Yuan JX, Shyy JY, Xiong N, Malhotra A.

Real-time CGM (rtCGM) during the COVID-19 Pandemic and its Impact on Time in Range

van der Linden J, Welsh JB, Hirsch IB, Garg SK.

Portable devices in ophthalmologyReply: portable devices in ophthalmologyDiabetic retinopathy screening and the COVID-19 pandemic in BRazilDiabetic retinopathy screening in urban primary care setting with a handheld smartphone-based retinal câmeraThe feasibility of smartphone based retinal phot

Ferraz DA, Sim DA, Belfort Junior R, Koh V.

Changes to Care Delivery at Nine International Pediatric Diabetes Clinics in Response to the COVID-19 Global Pandemic

Cristello Sarteau A, Souris KJ, Wang J, Ramadan AA, Addala A, Bowlby D, Corathers S, Forsander G, King B, Law JR, Liu W, Malik F, Pihoker C, Seid M, Smart C, Sundberg F, Tandon N, Yao M, Headley T, Mayer-Davis E.

Trends in Diabetes Care during the COVID-19 Outbreak in Japan: an Observational Study

Ikesu R, Miyawaki A, Sugiyama T, Nakamura M, Ninomiya H, Kobayashi Y.

Diabetes Might Augment the Severity of COVID-19: A Current Prospects

Sur J, Sharma J, Sharma D.

Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study

Jose J, Al-Dorzi HM, Al-Omari A, Mandourah Y, Al-Hameed F, Sadat M, Al Qasim E, Alraddadi B, Al Harthy A, Al Mekhlafi GA, Almotairi A, Al Khatib K, Abdulmomen A, Qushmaq I, Sindi AA, Mady A, Solaiman O, Al-Raddadi R, Maghrabi K, Ragab A, Kharaba A, Shalhoub S, Al-Aithan AM, Vishwakarma GK, Bhattacharjee A, Arabi YM; Saudi Critical Care Trials Group.

[Diabetes mellitus in the time of COVID-19]

Parhofer KG.

Minireview: The Introduction of COVID-19 and Microvascular Disease-Introduction of COVID-19 and the Relationship between Its Receptor and Diabetic Vascular Complications

Song Y, Ma Q, Lin P, Qin D, Lu D, Fan X.

Gut and glucose: an unusual first presentation of COVID-19

Daniels NF, Ridwan R.

Reply to: Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19

Lim S, Bae JH, Kwon HS, Nauck MA.

A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19

Morrison N, Barnett K, Tantum J, Morrison HK, Whalen M.

Metabolic Syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex and race of the patient with Metabolic Syndrome matter?

Lohia P, Kapur S, Benjaram S, Pandey A, Mir T, Seyoum B.

Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D

Hutchings N, Babalyan V, Baghdasaryan S, Qefoyan M, Sargsyants N, Aghajanova E, Martirosyan A, Harutyunyan R, Lesnyak O, Formenti AM, Giustina A, Bilezikian JP.

Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19

Boccardi V.

Virtual training on the hybrid close loop system in people with type 1 diabetes (T1D) during the COVID-19 pandemic

Gómez AM, Henao D, Parra D, Kerguelen A, Pinilla MV, Muñoz OM, Rondón M.

Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization

Kesavadev J, Misra A, Saboo B, Aravind SR, Hussain A, Czupryniak L, Raz I.

Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study

Ghosh A, Anjana RM, Shanthi Rani CS, Jeba Rani S, Gupta R, Jha A, Gupta V, Kuchay MS, Luthra A, Durrani S, Dutta K, Tyagi K, Unnikrishnan R, Srivastava BK, Ramu M, Sastry NG, Gupta PK, Umasankari G, Jayashri R, Mohan V, Misra A.

Impact of COVID-19 on Health Economics and Technology in Diabetes Care: Use cases of Real-Time Continuous Glucose Monitoring to Transform Healthcare During a Global Pandemic

Garg S, Norman G.

Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear

Yeh T, Yeung M, Mendelsohn Curanaj FA.

Association between thiamine deficiency and hyperlactatemia among critically ill patients with diabetes infected by SARS-CoV-2

Gonçalves SEAB, Gonçalves TJM, Guarnieri A, Risegato RC, Guimarães MP, de Freitas DC.

Clinical characteristics and outcomes of COVID-19 infected diabetic patients admitted in ICUs of the southern region of Bangladesh

Saha A, Ahsan MM, Quader MT, Naher S, Akter F, Mehedi HMH, Ullah Chowdhury AA, Karim MH, Rahman T, Parvin A.

Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study

Gou L, Xiang M, Ran X, Wang F, Zhang S, Li S, Dong K, Chen X, Huang Y, Meng C, Fan Q, Yang Y, Yu X, Ma D, Yin P.

Challenges and Opportunities for Diabetes Care in the Philippines in the Time of the COVID-19 Pandemic

Elvira Arcellana A, Jimeno C.

Position statement on COViD-19 infection and Diabetes

Philippine Society of Endocrinology, Diabetes and Metabolism.

Position Statement on How to Manage Patients with Diabetes and COVID-19

Indonesian Society of Endocrinology.

Diabetes and COVID-19: A Review

Baidya A, Singh SK, Bajaj S, Zargar AH, Singh P, Das S, Shankar A.

Use of Facebook to Serve Information Needs of Persons with Diabetes in the Philippines amid the COVID-19 Pandemic

Isip-Tan IT, Gutierrez J, Bernardo DC.

In-patient Care for People with COVID-19 and Diabetes in Myanmar

Aung AA, Ko K, Than KS, Ko Ko A, Naing MT.

UP Philippine General Hospital Division of Endocrinology, Diabetes & Metabolism Consensus Recommendations for In-Patient Management of Diabetes Mellitus among Persons with COVID-19

Jimeno C, Anonuevo-Cruz MC, Uy AB, Bacena AO, Francisco MD, Tiglao-Gica AL, Bruno R, Corpuz DG.

Response in Southeast Asia: Managing diabetes and other endocrine disorders during the COVID-19 crisis

Paz-Pacheco E.

Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people

Karatas S, Yesim T, Beysel S.

Is glucagon-like peptide 1 receptor analogues effective and safe in severe COVID-19 patients with type 2 diabetes?-a case report

Chen S, Lin W, Wen J, Xie B, Chen L, Chen G.

A Virtual Training Program for the Tandem t:slim X2 Insulin Pump: Implementation and Outcomes

Pinsker JE, Singh H, McElwee Malloy M, Constantin A, Leas S, Kriegel K, Habif S.

I fear COVID but diabetic foot (DF) is worse: a survey on patients' perception of a telemedicine service for DF during lockdown

Iacopi E, Pieruzzi L, Goretti C, Piaggesi A.

[Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic]

Mönkemöller K, Kamrath C, Hammersen J, Biester T, Warncke K, Pappa A, Fink K, Raile K, Rohrer TR, Holl RW; DPV Initiative.

Overall reduced lymphocyte especially T and B subsets closely related to the poor prognosis and the disease severity in severe patients with COVID-19 and diabetes mellitus

Liu D, Wang Y, Zhao B, Lan L, Liu Y, Bao L, Chen H, Yang M, Li Q, Zeng Y.

Diabetic Retinopathy Screening Using Artificial Intelligence and Handheld Smartphone-Based Retinal Camera

Malerbi FK, Andrade RE, Morales PH, Stuchi JA, Lencione D, de Paulo JV, Carvalho MP, Nunes FS, Rocha RM, Ferraz DA, Belfort R Jr.

Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU

Chow KW, Kelly DJ, Rieff MC, Skala PA, Kravets I, Charitou MM, Morley EJ, Gupta R, Miller JD.

Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19

Pazoki M, Keykhaei M, Kafan S, Montazeri M, Mirabdolhagh Hazaveh M, Sotoodehnia M, Kazemian S, Talebpour M, Ashraf H, Shariat Moharari R, Majidi F, Hedayati Amlashi N, Zare S, Fathi M, Azimbeik Z, Ebrahimi M.

Can COVID-19 cause diabetes?

Accili D.

Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic

Ruissen MM, Regeer H, Landstra CP, Schroijen M, Jazet I, Nijhoff MF, Pijl H, Ballieux BEPB, Dekkers O, Huisman SD, de Koning EJP.

11(1):1. doi: 10.1038/s41387-020-00147-8.","Boscari F","Nutr Diabetes","2021","2021/01/08","PMC7790327","","10.1038/s41387-020-00147-8"

9(1):e001858. doi: 10.1136/bmjdrc-2020-001858.","Izzi-Engbeaya C","BMJ Open Diabetes Res Care","2021","2021/01/07","PMC7789097","","10.1136/bmjdrc-2020-001858"

14(6):2245-2249. doi: 10.1016/j.dsx.2020.11.007. Epub 2020 Nov 17.","Soni M","Diabetes Metab Syndr","2020","2021/01/05","PMC7670909","","10.1016/j.dsx.2020.11.007"

14(6):2241-2243. doi: 10.1016/j.dsx.2020.11.013. Epub 2020 Nov 20.","Highton PJ","Diabetes Metab Syndr","2020","2021/01/05","PMC7677038","","10.1016/j.dsx.2020.11.013"

14(6):2219-2230. doi: 10.1016/j.dsx.2020.11.011. Epub 2020 Nov 17.","Yonas E","Diabetes Metab Syndr","2020","2021/01/05","PMC7669483","","10.1016/j.dsx.2020.11.011"

14(6):2211-2217. doi: 10.1016/j.dsx.2020.11.012. Epub 2020 Nov 17.","Boddu SK","Diabetes Metab Syndr","2020","2021/01/05","PMC7669477","","10.1016/j.dsx.2020.11.012"

14(6):2199-2203. doi: 10.1016/j.dsx.2020.11.001. Epub 2020 Nov 11.","Jayawardena R","Diabetes Metab Syndr","2020","2021/01/05","PMC7656158","","10.1016/j.dsx.2020.11.001"

14(6):2177-2183. doi: 10.1016/j.dsx.2020.11.006. Epub 2020 Nov 11.","Lukito AA","Diabetes Metab Syndr","2020","2021/01/05","PMC7657016","","10.1016/j.dsx.2020.11.006"

44:737-46)","Moon SJ, Rhee EJ, Lee WY, Yoon KH.","Diabetes Metab J. 2020 Dec

44(6):942-943. doi: 10.4093/dmj.2020.0266. Epub 2020 Dec 23.","Moon SJ","Diabetes Metab J","2020","2021/01/04","","","10.4093/dmj.2020.0266"

44:737-46)","Kim K, Oh TJ.","Diabetes Metab J. 2020 Dec

44(6):938-939. doi: 10.4093/dmj.2020.0236. Epub 2020 Dec 23.","Kim K","Diabetes Metab J","2020","2021/01/04","","","10.4093/dmj.2020.0236"

44(6):897-907. doi: 10.4093/dmj.2020.0199. Epub 2020 Dec 23.","Chun SY","Diabetes Metab J","2020","2021/01/04","","","10.4093/dmj.2020.0199"

Critical COVID-19 France Investigators.","Diabetes Metab. 2020 Dec 31:101222. doi: 10.1016/j.diabet.2020.101222. Online ahead of print.","Sutter W","Diabetes Metab","2020","2021/01/03","PMC7774010","","10.1016/j.diabet.2020.101222"

Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report

Ghosh A, Misra A.

Health literacy, preventive COVID 19 behaviour and adherence to chronic disease treatment during lockdown among patients registered at primary health facility in urban Jodhpur, Rajasthan

Gautam V, S D, Rustagi N, Mittal A, Patel M, Shafi S, Thirunavukkarasu P, Raghav P.

Reply to letter to the editor: "COVID-19 and the endocrine system: exploring the unexplored". Focus on acromegaly

Banerjee M, Pal R.

Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report

Pal R, Sachdeva N, Mukherjee S, Suri V, Zohmangaihi D, Ram S, Puri GD, Bhalla A, Soni SL, Pandey N, Bhansali A, Bhadada SK.

Diabetic patients with COVID-19 need more attention and better glycemic control

Xu M, Yang W, Huang T, Zhou J.

SARS-CoV-2 Infection Presenting with Hyperglycemia and Ketosis: A Case Series of Three Diabetic Patients

Kayina CA, Maitra S, Anand RK, Ray BR, Baidya DK, Subramaniam R.

Urine abnormalities predict acute kidney injury in COVID-19 patients: An analysis of 110 cases in Chennai, South India

Sundaram S, Soni M, Annigeri R.

The risk factors for mortality of diabetic patients with severe COVID-19: A retrospective study of 167 severe COVID-19 cases in Wuhan

Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang L, Zhang D.

Clinical Features and Risk Factors of ICU Admission for COVID-19 Patients with Diabetes

Lei M, Lin K, Pi Y, Huang X, Fan L, Huang J, Liu R, Liu L, Shao X, Hu K, Yang L, Qin S, He F.

Sleep-wake cycle impairment adding on the risk for COVID-19 severity in people with diabetes

Barone MTU, Ngongo B, Menna-Barreto L.

Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients With COVID-19 in Mexico

Peña JE, Rascón-Pacheco RA, Ascencio-Montiel IJ, González-Figueroa E, Fernández-Gárate JE, Medina-Gómez OS, Borja-Bustamante P, Santillán-Oropeza JA, Borja-Aburto VH.

CT-based staging and prognosis of novel coronavirus (COVID-19) pneumonia: correlation with blood glucose levels

Xu CC, Ruan XZ, Chen XQ, Huang QL, Zhao ZY, Ru L.

An overview of COVID-19 in people with diabetes pathophysiology and considerations in the inpatient setting

Fleming N, Sacks LJ, Pham C, Neoh SL, Ekinci E.

Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes

Sun Y, Zhao R, Hu Z, Wang W, Wang S, Gao L, Fei J, Jian X, Li Y, Zheng H, Hou X, Chen L.

Association of Daily Home-Based Hot Water Bathing and Glycemic Control in Ambulatory Japanese Patients with Type 2 Diabetes Mellitus During the COVID-19 Pandemic: A Multicenter Cross-Sectional Study

Kamioka H, Mori Y, Horiuchi T, Hayashi T, Ohmura K, Yamaguchi S, Kato M.

Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID-19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital

Sun Y, Guan X, Jia L, Xing N, Cheng L, Liu B, Zhang S, He K.

The influence of diabetes and hypertension on outcome in COVID-19 patients: Do we mix apples and oranges?

Tadic M, Cuspidi C.

New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry

Papachristou S, Stamatiou I, Stoian AP, Papanas N.

Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis

Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE.

Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities

Safdarian AR, Momenzadeh K, Kahe F, Farhangnia P, Rezaei N.

Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients

Oliveira TL, Melo IS, Cardoso-Sousa L, Santos IA, El Zoghbi MB, Shimoura CG, Georjutti RP, Castro OW, Goulart LR, Jardim ACG, Cunha TM, Sabino-Silva R.

Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes

Potier L, Hansel B, Larger E, Gautier JF, Carreira D, Assemien R, Lantieri O, Riveline JP, Roussel R.

Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic

Agarwal S, Mathew J, Davis GM, Shephardson A, Levine A, Louard R, Urrutia A, Perez-Guzman C, Umpierrez GE, Peng L, Pasquel FJ.

High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes

Mithal A, Jevalikar G, Sharma R, Singh A, Farooqui KJ, Mahendru S, Krishnamurthy A, Dewan A, Budhiraja S.

COVID-19 pandemic: can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy?

Nachtergaele C, Vicaut E, Pinto S, Tatulashvili S, Bihan H, Sal M, Berkane N, Allard L, Baudry C, Carbillon L, Cosson E.

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM, Mellor J, Jeyam A, O'Reilly JE, Wild SH, Hatam S, Höhn A, Colombo M, Robertson C, Lone N, Murray J, Butterly E, Petrie J, Kennon B, McCrimmon R, Lindsay R, Pearson E, Sattar N, McKnight J, Philip S, Collier A, McMenamin J, Smith-Palmer A, Goldberg D, McKeigue PM, Colhoun HM; Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology Group.

Observational research on severe COVID-19 in diabetes

Stehouwer CDA.

Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period

Ceccato F, Voltan G, Sabbadin C, Camozzi V, Merante Boschin I, Mian C, Zanotto V, Donato D, Bordignon G, Capizzi A, Carretta G, Scaroni C.

Bilateral retinal vein occlusion and diabetic retinopathy after COVID-19

Rego Lorca D, Rouco Fernandez A, Jimenez Santos M, Saenz-Frances F, Burgos-Blasco B, Donate Lopez J.

Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature

Singh AK, Singh R, Saboo B, Misra A.

Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium

Orioli L, Servais T, Belkhir L, Laterre PF, Thissen JP, Vandeleene B, Maiter D, Yombi JC, Hermans MP.

Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?

Sathish T, Cao Y.

Type 2 Diabetes and viral infection; cause and effect of disease

Turk Wensveen T, Gašparini D, Rahelić D, Wensveen FM.

[Screening for gestational diabetes due to of the COVID-19 pandemic]

Torosyan AO, Loginova EV, Gagaev CG.

[Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry]

Shestakova MV, Vikulova OK, Isakov MА, Dedov II.

Determinants of Mental Health Outcomes Among People With and Without Diabetes During the COVID-19 Outbreak in the Arab Gulf Region

Al-Sofiani ME, Albunyan S, Alguwaihes AM, Kalyani RR, Golden SH, Alfadda A.

Paediatric diabetes care during the COVID-19 pandemic: Lessons learned in scaling up telemedicine services

March CA, Flint A, DeArment D, Gilliland A, Kelly K, Rizzitano E, Chrisman A, Muzumdar RH, Libman IM.

Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection

Odriozola A, Ortega L, Martinez L, Odriozola S, Torrens A, Corroleu D, Martínez S, Ponce M, Meije Y, Presas M, Duarte A, Belén Odriozola M, Malik RA.

Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria

Raveendran AV.

Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adults Patients With and Without Type 2 Diabetes: A Cohort Study

Khalili S, Moradi O, Kharazmi AB, Raoufi M, Sistanizad M, Shariat M.

Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

De Luca G, Cercek M, Jensen LO, Vavlukis M, Calmac L, Johnson T, Roura I Ferrer G, Ganyukov V, Wojakowski W, von Birgelen C, Versaci F, Ten Berg J, Laine M, Dirksen M, Casella G, Kala P, Díez Gil JL, Becerra V, De Simone C, Carrill X, Scoccia A, Lux A, Kovarnik T, Davlouros P, Gabrielli G, Flores Rios X, Bakraceski N, Levesque S, Guiducci V, Kidawa M, Marinucci L, Zilio F, Galasso G, Fabris E, Menichelli M, Manzo S, Caiazzo G, Moreu J, Sanchis Forés J, Donazzan L, Vignali L, Teles R, Bosa Ojed

Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19

Roganović J.

Psychological impact of COVID-19 pandemic on chronic disease patients in Dessie town government and private hospitals, Northeast Ethiopia

Addis SG, Nega AD, Miretu DG.

A recalcitrant post-amputative diabetic foot ulcer treated with a new mechanical debridement system during COVID-19 lockdown

Vermigli C, Ceppitelli C, Lupattelli R, Eugeni E, Murdolo G.

microRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptors genes

Roganović JR.

Impact of Diabetes in Patients Diagnosed With COVID-19

Abu-Farha M, Al-Mulla F, Thanaraj TA, Kavalakatt S, Ali H, Abdul Ghani M, Abubaker J.

Comparison of Diabetic Ketoacidosis in Adults During the SARS-CoV-2 Outbreak and Over the Same Time Period for the Preceding 3 Years

Misra S, Khozoee B, Huang J, Mitsaki K, Reddy M, Salem V, Tan T, Tharakan G, Gable D, Bravis V, Valabhji J.

A Review of the Current Status of Gestational Diabetes Mellitus in Australia-The Clinical Impact of Changing Population Demographics and Diagnostic Criteria on Prevalence

Laurie JG, McIntyre HD.

Is metformin a miracle or a menace in COVID-19 patients with type 2 diabetes?

Lui DTW, Tan KCB.

Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes?

Lambadiari V, Kousathana F, Raptis A, Katogiannis K, Kokkinos A, Ikonomidis I.

Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey

Hassanein M, Alamoudi RM, Kallash MA, Aljohani NJ, Alfadhli EM, El Tony L, Khogeer GS, Alfadhly AF, ElMamoon Khater A, Yakoob Ahmedani M, Akif Buyukbese M, Shaltout I, Belkhadir J, Hafidh K, Chowdhury TA, Hussein Z, Samir Elbarbary N.

Evaluation of severe hypoglycemia and common mental disorders in patients receiving insulin analogues for treatment of type 1 diabetes

Berlanda G, Telo GH, Krug BC, Scheffel RS, Pasinato B, Iorra F, Dos Reis JG, Picon PD, Schaan BD.

Change in glucose-lowering medication regimen in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany

Jacob L, Rickwood S, Rathmann W, Kostev K.

Self care practices and psychological distress among diabetic patients in Manipur during COVID-19: A scenario from the North East

Bala R, Srivastava A, Potsangbam T, Anal L, Ningthoujam GD.

Hospital care: improving outcomes in type 1 diabetes

Boeder S, Kulasa K.

The Impact of the COVID-19 Pandemic on People with Diabetes and Diabetes Services: A pan-European Survey of Diabetes Specialist Nurses undertaken by the Foundation of European Nurses in Diabetes survey consortium

Forde R, Arente L, Ausili D, De Backer K, Due-Christensen M, Epps A, Fitzpatrick A, Grixti M, Groen S, Halkoaho A, Huber C, Iversen MM, Johansson UB, Leippert C, Ozcan S, Parker J, Paiva AC, Sanpetreanu A, Savet MA, Rosana SC, Szewczyk A, Valverde M, Vlachou E, Forbes A; FEND COVID-19 consortium.

Lung and Kidney ACE2 and TMPRSS2 in Renin Angiotensin System Blocker Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19

Batchu SN, Kaur H, Yerra VG, Advani SL, Kabir MG, Liu Y, Klein T, Advani A.

Are health care workers following preventive practices in the COVID-19 pandemic properly? - A cross-sectional survey from India

Agarwal A, Ranjan P, Saraswat A, Kasi K, Bharadiya V, Vikram N, Singh A, Upadhyay AD, Baitha U, Klanidhi KB, Chakrawarty A.

Managing Type 1 Diabetes among Saudi adults on insulin pump therapy during the COVID-19 lockdown

Magliah SF, Zarif HA, Althubaiti A, Sabban MF.

Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion

Das AK, Kalra S, B K, Sharma K, John M, Nair T, Shaikh S, Khandelwal D, Priya G, Dutta D, Gangadhar P, Dhingra A, Tiwaskar M, Shukla R, Das S, Baruah MP, Gangopadhyay KK, Ramakrishnan S, Deshmukh V, Dasgupta A, Kumar G, Pandey N, Joshi A, Surana VK, Punyani H, Shah P, Rattan A, Chandrasekaran S, Asirwatham A.

Management of patients with diabetes and obesity in the COVID-19 era: experiences and learnings from South and East Europe, the Middle East, and Africa

Giorgino F, Bhana S, Czupryniak L, Dagdelen S, Galstyan GR, Janež A, Lalić N, Nouri N, Rahelić D, Pantea Stoian A, Raz I.

Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study

Jiang N, Chen Z, Yin X, Liu L, Yang H, Tan X, Wang J, Li H, Tian M, Lu Z, Xiong N, Gong Y.

High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis

Lazarus G, Audrey J, Kharisma Wangsaputra V, Tamara A, Tahapary DL.

Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

Lalau JD, Al-Salameh A, Hadjadj S, Goronflot T, Wiernsperger N, Pichelin M, Allix I, Amadou C, Bourron O, Duriez T, Gautier JF, Dutour A, Gonfroy C, Gouet D, Joubert M, Julier I, Larger E, Marchand L, Marre M, Meyer L, Olivier F, Prevost G, Quiniou P, Raffaitin-Cardin C, Roussel R, Saulnier PJ, Seret-Begue D, Thivolet C, Vatier C, Desailloud R, Wargny M, Gourdy P, Cariou B; CORONADO investigators.

COVID-19 Associated with Diabetes and Other Noncommunicable Diseases Led to a Global Health Crisis

Thomaz Ugliara Barone M, Ngongo B, Bega Harnik S, Xavier de Oliveira L, Végh D, Vieira de Luca P, Cordeiro Pedrosa H, Giraudo F, Cardona-Hernandez R, Chaudhury N, Menna-Barreto L.

Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model

Bain SC, Czernichow S, Bøgelund M, Madsen ME, Yssing C, McMillan AC, Hvid C, Hettiarachchige N, Haagen Panton U.

Corrigendum to "Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients"

COVID-19 and diabetes: A bidirectional relationship

Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M.

Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea

You JH, Lee SA, Chun SY, Song SO, Lee BW, Kim DJ, Boyko EJ.

Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus

Liao YH, Zheng JQ, Zheng CM, Lu KC, Chao YC.

Diabetes Mellitus and Hypertension as Major Risk Factors of Mortality From Covid-19 Pneumonia

Petrakis V, Panagopoulos P, Papazoglou D, Papanas N.

Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq

Nafakhi H, Alareedh M, Al-Buthabhak K, Shaghee F, Nafakhi A, Kasim S.

[Healthcare challenges for people with diabetes during the national state of emergency due to COVID-19 in Lima, Peru: primary healthcare recommendations]

Pesantes MA, Lazo-Porras M, Cárdenas MK, Diez-Canseco F, Tanaka-Zafra JH, Carrillo-Larco RM, Bernabé-Ortiz A, Málaga G, Miranda JJ.

The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions

Yaribeygi H, Sathyapalan T, Jamialahmadi T, Sahebkar A.

Diabetes and COVID-19-Related Mortality in Women and Men in the UK Biobank: Comparisons With Influenza/Pneumonia and Coronary Heart Disease

de Jong M, Woodward M, Peters SAE.

Disordered eating behaviors in youths with type 1 diabetes during COVID-19 lockdown: an exploratory study

Troncone A, Chianese A, Zanfardino A, Cascella C, Piscopo A, Borriello A, Rollato S, Casaburo F, Testa V, Iafusco D.

Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China

Dai W, Wu J, Li T, Shen J, Pang R, Luo T, Guo Y, Yang Y, Zhao J, Zhang M, Li N, Han Y, Wu Q, Li W, Xia X.

Diabetic Foot Care Before and During the COVID-19 Epidemic: What Really Matters?

Urbančič-Rovan V.

Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus

Cheng Y, Yue L, Wang Z, Zhang J, Xiang G.

Digital Ophthalmology in the UK - Diabetic Retinopathy Screening and Virtual Glaucoma Clinics in the National Health Service

Heimann H, Broadbent D, Cheeseman R.

Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic

Palladino R, Migliatico I, Sgariglia R, Nacchio M, Iaccarino A, Malapelle U, Vigliar E, Salvatore D, Troncone G, Bellevicine C.

Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study

Bhatti R, Khamis AH, Khatib S, Shiraz S, Matfin G.

Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID-19; Data from a multi-site surveillance registry

Beliard K, Ebekozien O, Demeterco-Berggren C, Alonso GT, Gallagher MP, Clements M, Rapaport R.

Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads

Hoevenaar M, Goossens D, Roorda J.

Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.)

Zhao T, Peng L.

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study

Alguwaihes AM, Al-Sofiani ME, Megdad M, Albader SS, Alsari MH, Alelayan A, Alzahrani SH, Sabico S, Al-Daghri NM, Jammah AA.

People living with Type 1 diabetes point of view in COVID-19 times (COVIDT1 Study): disease impact, health system pitfalls and lessons for the future

Tejera C, Moreno-Pérez Ó, Rios J, Reyes-García R.

Coronavirus disease 2019 and type 1 diabetes mellitus

Chang DJ, Moin T.

Angiotensin Converting Enzyme Inhibitors, A Risk Factor of Poor Outcome in Diabetic Patients with COVID-19 Infection

Aghaaliakbari F, Abbasi MA, Ranjbar M, Jamshidi Makiani M, Farrokhpour M, Safarnezhad Tameshkel F, Karbalaie Niya MH, Doltkhah S, Yaghoobzadeh K, Savaj S.

Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19

Riahi S, Sombra LRS, Lo KB, Chacko SR, Neto AGM, Azmaiparashvili Z, Patarroyo-Aponte G, Rangaswami J, Anastasopoulou C.

Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic

Quinn LM, Davies MJ, Northern A, Brough C, Schreder S, Stribling B, Khunti K, Hadjiconstantinou M.

Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment

d'Emden M, McLeod D, Ungerer J, Appleton C, Kanowski D.

THE MAIN CAUSES OF THE COMPLICATED COURSE OF COVID-19 IN PATIENTS WITH DIABETES MELLITUS AND TREATMENT (REVIEW)

Halushko O, Loskutov O, Kuchynska I, Synytsyn M, Boliuk M.

What is the role of admission HbA1c in managing COVID-19 patients?

Sathish T, Cao Y.

New thoughts on the diagnosis and treatment of patients with diabetes mellitus in relation to coronavirus disease

Lou XQ, Wang DW, Wang JF, Du B.

COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes

Gregory JM, Slaughter JC, Duffus SH, Smith TJ, LeStourgeon LM, Jaser SS, McCoy AB, Luther JM, Giovannetti ER, Boeder S, Pettus JH, Moore DJ.

Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus

Park SD, Kim SW, Moon JS, Lee YY, Cho NH, Lee JH, Jeon JH, Choi YK, Kim MK, Park KG.

COVID-19 and Undiagnosed Pre-diabetes or Diabetes Mellitus Among International Migrant Workers in Singapore

Tee LY, Alhamid SM, Tan JL, Oo TD, Chien J, Galinato P, Tan SY, Humaira S, Fong RKC, Puar TH, Loh WJ, Santosa A, Khoo J, Rosario BH.

COVID-19 Knowledge, Attitudes, and Prevention Practices Among People with Hypertension and Diabetes Mellitus Attending Public Health Facilities in Ambo, Ethiopia

Melesie Taye G, Bose L, Beressa TB, Tefera GM, Mosisa B, Dinsa H, Birhanu A, Umeta G.

Managing diabetes in ageing patients during the COVID-19 pandemic

Armeni E, Paschou SA, Peppa M.

COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice?

Wee AKH.

Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients

Kumar A, Faiq MA, Pareek V, Raza K, Narayan RK, Prasoon P, Kumar P, Kulandhasamy M, Kumari C, Kant K, Singh HN, Qadri R, Pandey SN, Kumar S.

A role of glycation and methylation for SARS-CoV-2 infection in diabetes?

Sartore G, Ragazzi E, Faccin L, Lapolla A.

Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled type 2 diabetic patients

Emara MH, Mazid U, Atta MA, Elshahat S, Mahros AM.

Higher ACE2 expression levels in epicardial than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

Couselo-Seijas M, Almengló C, Agra-Bermejo R, Fernandez AL, Alvarez E, González-Juanatey JR, Eiras S.

The Urgent Need for Recommending Physical Activity for the Management of Diabetes During and Beyond COVID-19 Outbreak

Marçal IR, Fernandes B, Viana AA, Ciolac EG.

New Horizons: Does Mineralocorticoid Receptor activation by cortisol cause ATP release and COVID-19 complications?

Edwards C.

Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes

Yu B, Li C, Sun Y, Wang DW.

Assessing acceptability and patient experience of a behavioral lifestyle intervention using fitbit technology in older adults to manage type 2 diabetes amid COVID-19 pandemic: A focus group study

Jiwani R, Dennis B, Bess C, Monk S, Meyer K, Wang J, Espinoza S.

Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?

Donath MY.

Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis

Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P.

Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps

Wallia A, Prince G, Touma E, El Muayed M, Seley JJ.

[Diabetes mellitus in old age]

Zeyfang A, Zeeh J, Bahrmann A, Kugler JN, Heppner HJ.

A Rare Case of COVID-19 Myocarditis With Cardiac Tamponade in a Young Diabetic Adult With Renal Failure

Tiwary T, Baiswar S, Jinnur P.

Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial

Klarskov CK, Lindegaard B, Pedersen-Bjergaard U, Kristensen PL.

Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers

Dozio E, Sitzia C, Pistelli L, Cardani R, Rigolini R, Ranucci M, Corsi Romanelli MM.

The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes

Adu-Agyeiwaah Y, Grant MB, Obukhov AG.

Factors related to improvement of glycemic control among adults with type 1 diabetes during lockdown due to COVID-19

Moreno-Domínguez Ó, González-Pérez de Villar N, Barquiel B, Hillman N, Gaspar-Lafuente R, Arévalo-Gómez M, Herranz L.

Resilience in pregnant women with pre-gestational diabetes during COVID-19 pandemic: the experience of the Papa Giovanni XXIII Hospital in Bergamo, Italy

Dodesini AR, Caffi A, Spada MS, Trevisan R.

A trend towards early increases in ketoacidosis at presentation of pediatric type 1 diabetes during the coronavirus-2019 pandemic

Hawkes CP, Willi SM.

The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates

Liang X, Xu J, Xiao W, Shi L, Yang H.

Phenotypic Characteristics and Development of a Hospitalization Prediction Risk Score for Outpatients with Diabetes and COVID-19: The DIABCOVID Study

Lasbleiz A, Cariou B, Darmon P, Soghomonian A, Ancel P, Boullu S, Houssays M, Romain F, Lagier JC, Boucekine M, Resseguier N, Gourdy P, Pichelin M, Wargny M, Dutour A, Gaborit B.

Risk factors associated with the progression of COVID-19 in elderly diabetes patients

Zhang P, Wang M, Wang Y, Wang Y, Li T, Zeng J, Wang L, Li C, Gong Y.

Glycemic Control of Patients with Type 1 Diabetes Using an Insulin Pump Before and During the COVID-19-Associated Quarantine

Barmpagianni A, Lambadiari V, Papazafiropoulou A, Kountouri A, Stergiou A, Melidonis A, Liatis S.

A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post COVID-19 era

Choudhary P, Wilmot EG, Owen K, Patel DC, Mills L, Rayman G, Winocour P, Ayman G, Patel R, Hambling C, Nagi DK.

Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily

Silverii GA, Monami M, Cernigliaro A, Vigneri E, Guarnotta V, Scondotto S, Allotta VA, Conti M, Giordano C, Mannucci E.

Higher values of fasting blood glucose and glycated hemoglobin are not associated with mortality in Covid-19 Mexican patients

Gastélum-Cano JM, Islas-Osuna MA, Arízaga-Berber JA.

Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis

Bud ES, Vlasa A, Bud A.

Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19

Ji D, Zhang M, Qin E, Zhang L, Xu J, Wang Y, Cheng G, Wang F, Lau G.

Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study

Biancalana E, Parolini F, Mengozzi A, Solini A.

The dark side of the spoon - glucose, ketones and COVID-19: a possible role for ketogenic diet?

Paoli A, Gorini S, Caprio M.

Association of glycosylated hemoglobin and outcomes in patients with COVID-19 and pre-existing type 2 diabetes: A protocol for systematic review and meta-analysis

Zhang N, Yun R, Liu L, Yang L.

Does Inpatient Hyperglycemia predict a worse outcome in COVID-19 Intensive Care Unit Patients?

Saand AR, Flores M, Kewan T, Alqaisi S, Alwakeel M, Griffiths L, Wang X, Han X, Burton R, Al Jaghbeer MJ, Fadel FA.

Pre-diabetes and COVID-19, could we be missing the silent killer?

Sosibo AM, Khathi A.

Diabetes and COVID-19: a major challenge in pandemic period?

Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Agoramoorthy G, Lee SS.

Coagulopathy is a major extrapulmonary risk factor for mortality in hospitalized patients with COVID-19 with type 2 diabetes

Chen X, Chen Y, Wu C, Wei M, Xu J, Chao YC, Song J, Hou D, Zhang Y, Du C, Li X, Song Y.

COVID-19: No one must be left behind

Tieri L.

[Covid-19 and diabetes]

Paquot N, Radermecker RP.

M♡THer, a mHealth System to Support Women with Gestational Diabetes Mellitus - Feasibility and Acceptability Study

Varnfield M, Redd C, Stoney R, Higgins L, Scolari N, Warwick R, Iedema J, Rundle J, Dutton W.

The potential effects of clinical antidiabetic agents on SARS-CoV-2

Qu H, Zheng Y, Wang Y, Li H, Liu X, Xiong X, Zhang L, Gu J, Yang G, Zhu Z, Zheng H, Ouyang Q.

Recent trends for the management of diabetes for older adults in the context of universal coverage and COVID-19: evidence from Mexico

Arredondo A.

COVID 19 and diabetes: An endocrinologist's perspective

Behera KK, Hota D, Mahapatra A.

Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2

Elamari S, Motaib I, Zbiri S, Elaidaoui K, Chadli A, Elkettani C.

Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages

Sosa-Rubí SG, Seiglie JA, Chivardi C, Manne-Goehler J, Meigs JB, Wexler DJ, Wirtz VJ, Gómez-Dantés O, Serván-Mori E.

Innovations in Diabetes Care for a Better "New Normal" Beyond COVID-19

Agarwal S, Griffith ML, Murphy EJ, Greenlee C, Boord J, Gabbay RA.

Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19

Cardona-Hernandez R, Cherubini V, Iafusco D, Schiaffini R, Luo X, Maahs DM.

Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report

Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB.

An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms

Hayden MR.

Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension

Fitzgerald K.

Use of DPP-4 inhibitors in patients with COVID-19

Kow CS, Hasan SS.

Reply to letter to the editor regarding "Use of DPP-4 inhibitors in patients with COVID-19"

Solerte SB, D'Addio F, Fiorina P.

Covid-19 fatality prediction in people with diabetes and prediabetes using a simple score at hospital admission

Sourij H, Aziz F, Bräuer A, Ciardi C, Clodi M, Fasching P, Karolyi M, Kautzky-Willer A, Klammer C, Malle O, Oulhaj A, Pawelka E, Peric S, Ress C, Sourij C, Stechemesser L, Stingl H, Stulnig TM, Tripolt N, Wagner M, Wolf P, Zitterl A, Kaser S; COVID-19 in Diabetes in Austria - study group.

Host genetic liability for severe COVID-19 overlaps with alcohol drinking behavior and diabetic outcomes and in over 1 million participants

Wendt FR, De Lillo A, Pathak GA, De Angelis F, Polimanti R.

Images of the month: An incidental finding of spontaneous pneumomediastinum (Hamman's syndrome) secondary to diabetic ketoacidosis during the coronavirus pandemic

Marchon KA, Nunn MO, Chakera AJ.

Maintaining Blood Glucose Levels in Range (70-150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients-A Retrospective Analysis

Kapoor R, Timsina LR, Gupta N, Kaur H, Vidger AJ, Pollander AM, Jacobi J, Khare S, Rahman O.

Blood Glucose Control Strategy for Type 2 Diabetes Patients With COVID-19

Futatsugi H, Iwabu M, Okada-Iwabu M, Okamoto K, Amano Y, Morizaki Y, Kadowaki T, Yamauchi T.

COVID-19 Precipitating Euglycaemic Diabetic Ketoacidosis with SGLT2 Inhibitor Use

Fang J, Genco M, Caskey RN.

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Pérez-Belmonte LM, Torres-Peña JD, López-Carmona MD, Ayala-Gutiérrez MM, Fuentes-Jiménez F, Huerta LJ, Muñoz JA, Rubio-Rivas M, Madrazo M, Garcia MG, Montes BV, Sola JF, Ena J, Ferrer RG, Pérez CM, Ripper CJ, Lecumberri JJN, Acedo IEA, Canteli SP, Cosío SF, Martínez FA, Rodríguez BC, Pérez-Martínez P, Ramos-Rincón JM, Gómez-Huelgas R; SEMI-COVID-19 Network.

Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh, Saudi Arabia

Sheshah E, Sabico S, Albakr RM, Sultan AA, Alghamdi KS, Al Madani K, Alotair HA, Al-Daghri NM.

Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?

Alvarado-Vasquez N.

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Lim S, Bae JH, Kwon HS, Nauck MA.

Impact of lockdown for COVID-19 pandemic in Indian children and youth with type 1 diabetes from different socio-economic classes

Shah N, Karguppikar M, Bhor S, Ladkat D, Khadilkar V, Khadilkar A.

An inaugural diabetic ketoacidosis with acute pancreatitis during COVID-19

Tollard C, Champenois V, Delemer B, Carsin-Vu A, Barraud S.

Thyroid function before, during and after COVID-19

Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, Phylactou M, Eng PC, Thurston L, Alexander EC, Meeran K, Comninos AN, Abbara A, Dhillo WS.

Women with mild fasting hyperglycemia in early pregnancy have more neonatal intensive care admissions

Benhalima K, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, Vercammen C, Maes T, Dufraimont E, De Block C, Jacquemyn Y, Mekahli F, De Clippel K, Van Den Bruel A, Loccufier A, Laenen A, Minschart C, Devlieger R, Mathieu C.

New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19

Naguib MN, Raymond JK, Vidmar AP.

A review of COVID-19 vaccines and major considerations for diabetic patients

Soltani S, Zandi M, Aghbash PS, Rezaei M, Mohammadzadeh N, Afsharifar A, Poortahmasebi V.

COVID-19 in the United States: Where are we now? Where have we been?

Bloomgarden Z.

Sex differences in COVID-19: the role of androgens in disease severity and progression

Mohamed MS, Moulin TC, Schiöth HB.

COVID-19 in People with Diabetes: Perspectives from Saudi Arabia

Robert AA, Al Dawish MA.

Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus

Pla B, Arranz A, Knott C, Sampedro M, Jiménez S, Hernando I, Marazuela M.

Clinical features of critically ill patients infected with SARS-CoV-2 outside Wuhan with and without diabetes

Peng X, Chen Y, Deng L, Liu Q, Li Q, Xiong J, Shi Y, Tang S.

Telemonitoring type 1 diabetes patients during the COVID-19 pandemic in Brazil: was it useful?

de Mattos Matheus AS, Cabizuca CA, Tannus LRM, Passos AC, Schmidt AC, de Gouveia AT, de Albuquerque Pessoa BM, Matheus FC, Yang GY, da Silva Divino JA, Mathiles JA, Teixeira JL, de Souza Barroso L, da Fonseca de Brito MB, Suassuna PM, Cobas RA.

Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients

di Filippo L, Formenti AM, Doga M, Frara S, Rovere-Querini P, Bosi E, Carlucci M, Giustina A.

COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multi-Center Surveillance Study

O'Malley G, Ebekozien O, Desimone M, Pinnaro CT, Roberts A, Polsky S, Noor N, Aleppo G, Basina M, Tansey M, Steenkamp D, Vendrame F, Lorincz I, Mathias P, Agarwal S, Golden L, Hirsh IB, Levy CJ.

Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'

Abbasi-Oshaghi E, Mirzaei F, Khodadadi I.

Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis

Tuty Kuswardhani RA, Henrina J, Pranata R, Anthonius Lim M, Lawrensia S, Suastika K.

Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients

Anurag A, Jha PK, Kumar A.

Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?

Do JY, Kim SW, Park JW, Cho KH, Kang SH.

Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes

di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A.

Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection

Hernández JL, Nan D, Fernandez-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M, Muñoz-Cacho P, Olmos JM, Gutiérrez-Cuadra M, Ruiz-Cubillán JJ, Crespo J, Martínez-Taboada VM.

Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia

Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE.

Onset of Ketosis-Prone Diabetes in the Setting of COVID-19 Infection

Siddiqui RS, Zirkiyeva M, Saliaj M.

TEMPORARY REMOVAL: Diabetic retinopathy is independently associated with increased risk of intubation: a single centre cohort study of patients with diabetes hospitalised with COVID-19

Corcillo A, Cohen S, Li A, Crane J, Kariyawasam D, Karalliedde J.

Severity in pediatric type 1 diabetes mellitus debut during the COVID-19 pandemic

Güemes M, Storch-de-Gracia P, Enriquez SV, Martín-Rivada Á, Brabin AG, Argente J.

Social Determinants of Poor Management of Type 2 Diabetes Among the Insured

Patel MR.

The Danger of Sedentary Lifestyle in Diabetic and Obese People During the COVID-19 Pandemic

Lim MA, Pranata R.

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials

Ploumen EH, Buiten RA, Kok MM, Doggen CJM, Roguin A, Jessurun GAJ, Schotborgh CE, Danse PW, Benit E, Aminian A, van Houwelingen KG, Stoel MG, Scholte M, Hartmann M, Linssen GCM, Zocca P, von Birgelen C.

Thyroid Dysfunction in Relation to Immune Profile, Disease Status and Outcome in 191 Patients with COVID-19

Lui DTW, Lee CH, Chow WS, Lee ACH, Tam AR, Fong CHY, Law CY, Leung EKH, To KKW, Tan KCB, Woo YC, Lam CW, Hung IFN, Lam KSL.

Thyroid hormone concentrations in severely or critically ill patients with COVID-19

Gao W, Guo W, Guo Y, Shi M, Dong G, Wang G, Ge Q, Zhu J, Zhou X.

Antidiabetes Agents against Sars-Cov-2 Infection

Vitiello A, Ferrara F.

Implications of COVID-19 Pandemic on Evolution of Diabetes in Malaria-Endemic African Region

Acquah S.

COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report

Batista DV, Vieira CAFA, Costa TA, Lima EG.

Prevalence and impact of diabetes in patients with COVID-19 in China

Du M, Lin YX, Yan WX, Tao LY, Liu M, Liu J.

Covid-19 and Diabetes: A Complex Bidirectional Relationship

Muniangi-Muhitu H, Akalestou E, Salem V, Misra S, Oliver NS, Rutter GA.

Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: Case series

Alsadhan I, Alruwashid S, Alhamad M, Alajmi S, Alshehri S, Alfadhli E, Ekhzaimy A.

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Sathish T, Tapp RJ, Cooper ME, Zimmet P.

Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?

Lippi G, Sanchis-Gomar F, Henry BM.

Prenatal exposure to gestational diabetes is associated with anxiety and physical inactivity in children during COVID-19

Alves JM, Yunker AG, DeFendis A, Xiang AH, Page KA.

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care. Analysis from an outbreak area in North-East Italy

Bonora BM, Morieri ML, Avogaro A, Fadini GP.

The influence of hypoglycemia and hyperglycemia on the adverse outcome of COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis

Yang Y, Chen XFD, Chen Y, Xie H, Xie C, Ying L.

Analysis of clinical features and pulmonary CT features of coronavirus disease 2019 (COVID-19) patients with diabetes mellitus

Yan Y, Yang F, Zhu X, Wang M, Sun Z, Zhao T, Yang X, Zou Y.

Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump

Viñals C, Mesa A, Roca D, Vidal M, Pueyo I, Conget I, Giménez M.

Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients

Palaiodimos L, Chamorro-Pareja N, Karamanis D, Li W, Zavras PD, Chang KM, Mathias P, Kokkinidis DG.

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

Galiero R, Pafundi PC, Nevola R, Rinaldi L, Acierno C, Caturano A, Salvatore T, Adinolfi LE, Costagliola C, Sasso FC.

Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?

Semiz S, Serdarevic F.

The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis

Chen J, Wu C, Wang X, Yu J, Sun Z.

The adverse effects of novel coronavirus on diabetic foot patients: A protocol for systematic review and meta analysis

Chen D, Zhou H, Yang Y, Zhang Y, Xie C.

Statins and SARS-CoV-2 disease: Current concepts and possible benefits

Minz MM, Bansal M, Kasliwal RR.

Challenges in Women with Diabetes During the COVID-19 Pandemic

Priya G, Bajaj S, Grewal E, Maisnam I, Chandrasekharan S, Selvan C.

Managing Diabetes During the COVID-19 Pandemic

Doupis J, Avramidis K.

Barriers to Self-Management of Type 2 Diabetes During COVID-19 Medical Isolation: A Qualitative Study

Shi C, Zhu H, Liu J, Zhou J, Tang W.

Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study

Di Dalmazi G, Maltoni G, Bongiorno C, Tucci L, Di Natale V, Moscatiello S, Laffi G, Pession A, Zucchini S, Pagotto U.

Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic

Ozer O, Yorulmaz G.

Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study

Moon SJ, Rhee EJ, Jung JH, Han KD, Kim SR, Lee WY, Yoon KH.

Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19

Kuchay MS, Reddy PK, Gagneja S, Mathew A, Mishra SK.

Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh

Akter F, Mannan A, Mehedi HMH, Rob MA, Ahmed S, Salauddin A, Hossain MS, Hasan MM.

Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes

Huang J, Zhu L, Bai X, Jia X, Lu Y, Deng A, Li J, Jin S.

Inpatient Diabetes Care during the COVID-19 Pandemic: A Diabetes UK rapid review of health care professionals' experiences using semi-structured interviews

Burr O, Berry A, Joule N, Rayman G.

Coronavirus disease 2019 (COVID-19): Insights into the recent trends and the role of the primary care in diabetic patients

Marghalani AM, Althumali IM, Yousef LM, Alharthi MA, Alahmari ZS, Kabel AM.

Management of diabetes during fasting and COVID-19 - Challenges and solutions

Ahmed WN, Arun CS, Koshy TG, Nair A, Sankar P, Rasheed SA, Ann R.

Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?

Sathish T, de Mello GT, Cao Y.

Adrenal insufficiency at the time of COVID-19: a retrospective study in patients referring to a tertiary centre

Carosi G, Morelli V, Del Sindaco G, Serban AL, Cremaschi A, Frigerio S, Rodari G, Profka E, Indirli R, Mungari R, Resi V, Orsi E, Ferrante E, Dolci A, Giavoli C, Arosio M, Mantovani PG.

A post COVID-19 "Marshall Plan" for type 2 diabetes

Petrie JR, Boyle JG, Ali K, Smith C, Morrison D, Kar P.

Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study

Rastogi A, Hiteshi P, Bhansali A.

COVID-19-Induced Diabetic Ketoacidosis and Acute Respiratory Distress Syndrome in an Obese 24-Year-Old Type I Diabetic

Singh S, Foster A, Khan Z, Siddiqui A, Atere M, Nfonoyim JM.

Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients

Ikewaki N, Iwasaki M, Abraham SJK.

The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review

Sciberras J, Camilleri LM, Cuschieri S.

Macrophages in diabetes mellitus (DM) and COVID-19: do they trigger DM?

Kloc M, Ghobrial RM, Lewicki S, Kubiak JZ.

COVID-19 and diabetes mellitus: Unraveling the hypotheses that worsen the prognosis (Review)

Albulescu R, Dima SO, Florea IR, Lixandru D, Serban AM, Aspritoiu VM, Tanase C, Popescu I, Ferber S.

SARS-CoV 2 (Covid-19) Heterogeneous Mortality Rates across Countries May Be Partly Explained by Life Expectancy, Calorie Intake, and Prevalence of Diabetes

Nkhata SG, Ngoma TN, Chilenga PM.

High prevalence of Afro-Caribbean ethnicity and hypoglycaemia in patients with diabetes and end stage renal disease hospitalised with COVID-19

Corcillo A, Cohen S, Game D, Karalliedde J.

Management of gestational diabetes in women with a concurrent Sars-Cov-2 infection, experience of a single center in Northern Italy

D'Ambrosi F, Rossi G, Soldavini CM, Maggi V, Cetera GE, Carbone IF, Di Martino D, Di Maso M, Ferrazzi E.

Mechanistic basis and therapeutic relevance of hypocalcemia during severe COVID-19 infection

Singh VP, Khatua B, El-Kurdi B, Rood C.

Impact of COVID-19 on lifestyle-related behaviours- a cross-sectional audit of responses from nine hundred and ninety-five participants from India

Chopra S, Ranjan P, Singh V, Kumar S, Arora M, Hasan MS, Kasiraj R, Suryansh, Kaur D, Vikram NK, Malhotra A, Kumari A, Klanidhi KB, Baitha U.

Young people with type 1 diabetes on insulin pump therapy could fast safely during COVID 19 pandemic Ramadan - a telemonitoring experience in Bangladesh

Zabeen B, Ahmed B, Nahar J.

Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020

Dennis JM, Mateen BA, Sonabend R, Thomas NJ, Patel KA, Hattersley AT, Denaxas S, McGovern AP, Vollmer SJ.

Normal weight obesity and COVID-19 severity: A poorly recognized link

Sathish T, Kapoor N.

Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: a matter of sexual dimorphism?

Huh K, Lee R, Ji W, Kang M, Cheol Hwang I, Ho Lee D, Jung J.

Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease

Milder TY, Stocker SL, Day RO, Greenfield JR.

Hypocalcemia: the quest for the cause of a major biochemical feature of COVID-19

di Filippo L, Formenti AM, Giustina A.

Managing high-acuity outpatient services during the COVID-19 pandemic: lessons from the acute diabetes foot service

Deogon GS, Robbins T, Randeva MS, Kyrou I, Sankar S, Randeva HS, Murthy N.

The role of androgens in COVID-19

Moradi F, Enjezab B, Ghadiri-Anari A.

Routine use of statins and increased mortality related to COVID-19 in inpatients with type 2 diabetes: Results from the CORONADO study

Cariou B, Goronflot T, Rimbert A, Boullu S, Le May C, Moulin P, Pichelin M, Potier L, Smati S, Sultan A, Tramunt B, Wargny M, Gourdy P, Hadjadj S; CORONADO investigators.

COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region

Al Dawish MA, Robert AA.

Use of Continuous Glucose Monitoring to Assess TPN-induced Hyperglycemia in an Adult Patient with Severe COVID-19

Chow KW, Kelly DJ, Gupta R, Miller JD.

Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients

Jankovic I, Basina M.

The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases

Evin F, Er E, Ata A, Jalilova A, Demir G, Atik Altınok Y, Özen S, Darcan Ş, Gökşen D.

Incidental COVID-19 Pneumonia on Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: The "New-normal"

Sharma P.

Response to Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433-1434

McIntyre HD, Moses RG.

Comment on McIntyre and Moses The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic. Diabetes Care 2020;43:1433-1434

Issa BG, Becker L, Cheer K, Kelly AM.

A nutritional web-based approach in obesity and diabetes before and during COVID-19 lockdown

Fraticelli F, Nicola MD, Vitacolonna E.

Application of tele-podiatry in diabetic foot management: A series of illustrative cases

Kavitha KV, Deshpande SR, Pandit AP, Unnikrishnan AG.

Comments on "ARIMA modelling & forecasting of COVID-19 in top five affected countries"(by Alok Kumar Sahai, Namita Rath, Vishal Sood, Manvendra Pratap Singh)

Kufel T, Kufel P.

Diabetes, D-dimer and COVID-19: The possible role of glucose control

Ceriello A.

The impact of metabolic syndrome on morbidity and mortality among intensive care unit admitted COVID-19 patients

Alamdari NM, Rahimi FS, Afaghi S, Zarghi A, Qaderi S, Tarki FE, Ghafouri SR, Besharat S.

COVID-19: Impact of obesity and diabetes on disease severity

Al-Sabah S, Al-Haddad M, Al-Youha S, Jamal M, Almazeedi S.

Prise en charge du diabète de type 2 en soins primaires durant la pandémie de la COVID-19

Kiran T, Moonen G, Bhattacharyya OK, Agarwal P, Bajaj HS, Kim J, Ivers N.

Managing type 2 diabetes in primary care during COVID-19

Kiran T, Moonen G, Bhattacharyya OK, Agarwal P, Bajaj HS, Kim J, Ivers N.

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

Ugliara Barone MT, Harnik SB, Chaluppe M, Vieira de Luca P, Ngongo B, Pedrosa HC, Pirolo V, Franco DR, Malta DC, Giampaoli V.

Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy

Barchetta I, Agata Cimini F, Bertoccini L, Ceccarelli V, Spaccarotella M, Giorgio Baroni M, Gisella Cavallo M.

Diabetes begünstigt Nierenversagen bei COVID-19-Patienten : Corona-Pandemie -- Autor: E. Fritschka

Fritschka E.

Time in range: a best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic

Wilmot EG, Lumb A, Hammond P, Murphy HR, Scott E, Gibb FW, Platts J, Choudhary P.

Effect of COVID-19 pandemic on treatment of Type 1 diabetes in children

Ludvigsson J.

Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19

Yang P, Wang N, Wang J, Luo A, Gao F, Tu Y.

Factors associated with the poor outcomes in diabetic patients with COVID-19

Rastad H, Ejtahed HS, Mahdavi-Ghorabi A, Arzaghi M, Safari A, Shahrestanaki E, Rezaei M, Niksima MM, Zakani A, Dehghan Manshadi SH, Ochi F, Saedi S, Khodaparast Z, Shafiabadi Hassani N, Azimzadeh M, Qorbani M.

Evaluation of telephone and virtual visits for routine pediatric diabetes care during the COVID-19 pandemic

Fung A, Irvine M, Ayub A, Ziabakhsh S, Amed S, Hursh BE.

Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China

Zhang N, Wang C, Zhu F, Mao H, Bai P, Chen LL, Zeng T, Peng MM, Qiu KL, Wang Y, Yu M, Xu S, Zhao J, Li N, Zhou M.

Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report

Beretta F, Dassie F, Parolin M, Boscari F, Barbot M, Busetto L, Mioni R, De Carlo E, Scaroni C, Fallo F, Vettor R, Maffei P.

SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review

Deravi N, Fathi M, Vakili K, Yaghoobpoor S, Pirzadeh M, Mokhtari M, Fazel T, Ahsan E, Ghaffari S.

Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study

Ghesquière L, Garabedian C, Drumez E, Lemaître M, Cazaubiel M, Bengler C, Vambergue A.

Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic

Tao J, Gao L, Liu Q, Dong K, Huang J, Peng X, Yang Y, Wang H, Yu X.

Seasonal flu and COVID-19 recommendations for children, adolescents and young adults with diabetes

Scaramuzza AE, Rabbone I, Maffeis C, Schiaffini R; Diabetes Study Group of the Italian Society for Pediatric Endocrinology, Diabetes.

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England

Prabhu Navis J, Leelarathna L, Mubita W, Urwin A, Rutter MK, Schofield J, Thabit H.

Identification and Resolution of Asymptomatic COVID-19 Pneumonitis and Colitis: Serial Assessment of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Evaluation of Lung Cancer

Kidane B, Levin DP.

Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report

Jornayvaz FR, Assouline B, Pugin J, Gariani K.

Deadly Companions: COVID-19 and Diabetes in Mexico

Singer M.

Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study

Sadhu AR, Serrano IA, Xu J, Nisar T, Lucier J, Pandya AR, Patham B.

Admission hyperglycemiaas a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry

Carrasco-Sánchez FJ, López-Carmona MD, Martínez-Marcos FJ, Pérez-Belmonte LM, Hidalgo-Jiménez A, Buonaiuto V, Suárez Fernández C, Freire Castro SJ, Luordo D, Pesqueira Fontan PM, Blázquez Encinar JC, Magallanes Gamboa JO, de la Peña Fernández A, Torres Peña JD, Fernández Solà J, Napal Lecumberri JJ, Amorós Martínez F, Guisado Espartero ME, Jorge Ripper C, Gómez Méndez R, Vicente López N, Román Bernal B, Rojano Rivero MG, Ramos Rincón JM, Gómez Huelgas R; SEMI-COVID-19 Networ

Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia

Zhou W, Ye S, Wang W, Li S, Hu Q.

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Zhao R, Sun Y, Zhang Y, Wang W, Wang S, Wang C, Liu J, Gao L, Hu Z, Fei J, Hou X, Zheng H, Chen L.

Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes

Psoma O, Papachristoforou E, Kountouri A, Balampanis K, Stergiou A, Lambadiari V, Liatis S, Tsimihodimos V.

The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study

Fisher L, Polonsky W, Asuni A, Jolly Y, Hessler D.

Effect of COVID19 pandemic and national lockdown on persons with diabetes from rural areas availing care in a tertiary care center, southern India

Olickal JJ, Chinnakali P, Suryanarayana BS, Ulaganeethi R, Kumar SS, Saya GK.

The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey

Önmez A, Gamsızkan Z, Özdemir Ş, Kesikbaş E, Gökosmanoğlu F, Torun S, Cinemre H.

Estimated HbA(1c) and glucose management indicator (GMI): are they the same?

Leelarathna L, Thabit H, Hovorka R, Evans M.

Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients

Hasan SS, Kow CS, Bain A, Kavanagh S, Merchant HA, Hadi MA.

Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Patoulias D, Papadopoulos C, Katsimardou A, Toumpourleka M, Doumas M.

A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Bossi AC, Forloni F, Colombelli PL.

Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study

Smati S, Tramunt B, Wargny M, Caussy C, Gaborit B, Vatier C, Vergès B, Ancelle D, Amadou C, Bachir LA, Bourron O, Coffin-Boutreux C, Barraud S, Dorange A, Fremy B, Gautier JF, Germain N, Larger E, Laugier-Robiolle S, Meyer L, Monier A, Moura I, Potier L, Sabbah N, Seret-Bégué D, Winiszewski P, Pichelin M, Saulnier PJ, Hadjadj S, Cariou B, Gourdy P; CORONADO investigators.

Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters

Alahmad B, Al-Shammari AA, Bennakhi A, Al-Mulla F, Ali H.

Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China

Tao F, Tang X, Tao H, Luo Y, Cao H, Xiang W, Zhao Y, Jin L.

COVID-19 and diabetes: No time to drag our feet during an untimely pandemic

Kyrou I, Robbins T, Randeva HS.

COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail

Pal R, Bhasin MK, Bhadada SK.

Clouds and Silver Linings.COVID-19 Pandemic Is an Opportune Moment to Democratize Diabetes Care Through Telehealth

Kerr D, Warshaw H.

Important Role of Relaxation Techniques on Immune Functions, Glycemic Control, and Stress in Diabetic patients with COVID-19: A Review

Mahmoud Mohamed AA, Alawna M.

Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle

Holly JMP, Biernacka K, Maskell N, Perks CM.

Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes

Maiorino MI, Bellastella G, Longo M, Caruso P, Esposito K.

Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with pre-existing diabetes: a multicenter observational study

Ling P, Luo S, Zheng X, Cai G, Weng J.

Sperm cryopreservation during the SARS-CoV-2 pandemic

Paoli D, Pallotti F, Nigro G, Aureli A, Perlorca A, Mazzuti L, Di Carlo D, Turriziani O, Lenzi A, Lombardo F.

Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients

Kumar A, Kumar P, Dungdung A, Kumar Gupta A, Anurag A, Kumar A.

SARS-CoV-2 receptor networks in diabetic and COVID-19 associated kidney disease

Menon R, Otto EA, Sealfon R, Nair V, Wong AK, Theesfeld CL, Chen X, Wang Y, Boppana AS, Luo J, Yang Y, Kasson PM, Schaub JA, Berthier CC, Eddy S, Lienczewski CC, Godfrey B, Dagenais SL, Sohaney R, Hartman J, Fermin D, Subramanian L, Looker HC, Harder JL, Mariani LH, Hodgin JB, Sexton JZ, Wobus CE, Naik AS, Nelson RG, Troyanskaya OG, Kretzler M.

Type 2 diabetic Asian Indians and COVID-19: Lessons learnt so far from the ongoing pandemic

Shivane VK, Lila AR, Bandgar TR.